data_2lcy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' HG22 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.408 ' HG2' ' O ' ' A' ' 509' ' ' PRO . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.495 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.51 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.593 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.3 OUTLIER -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.3 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 515' ' ' LEU . 6.4 t-160 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.602 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.404 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.602 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.495 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.587 ' O ' HG21 ' A' ' 532' ' ' ILE . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.506 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.506 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 33.8 m-80 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 507' ' ' ALA . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.442 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 1.5 pt20 -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.617 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.613 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.639 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.486 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.466 ' HB ' ' CE1' ' A' ' 543' ' ' TYR . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.473 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.473 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.524 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.617 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.502 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.423 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.617 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.1 t-20 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.672 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.672 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.476 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.443 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.476 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 546' ' ' GLY . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 31.2 m-80 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.538 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.617 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.538 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.649 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 2.5 t-20 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.41 ' CD2' ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.572 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.676 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.676 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.448 ' CZ ' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 532' ' ' ILE . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.553 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.595 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.524 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.857 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.9 t-20 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.857 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.483 ' O ' ' CG2' ' A' ' 519' ' ' THR . 0.8 OUTLIER 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.525 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 525' ' ' ALA . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.637 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 519' ' ' THR . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 532' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 534' ' ' TYR . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.459 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.576 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.591 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.572 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.645 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.436 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.498 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 549' ' ' HIS . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.591 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.543 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.411 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.2 mm-40 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 516' ' ' HIS . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HB2' ' ND2' ' A' ' 512' ' ' ASN . 0.6 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.433 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 520' ' ' THR . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 524' ' ' GLY . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 550' ' ' ASN . 2.8 tp60 -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.401 ' N ' HD12 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.491 HD11 ' CD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.451 ' CG2' ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 544' ' ' ILE . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 6.3 m120 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.48 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.697 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.6 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.6 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.0 t-20 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 513' ' ' PRO . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 523' ' ' GLU . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.414 ' O ' ' CG1' ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.415 ' O ' ' CZ2' ' A' ' 531' ' ' TRP . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.415 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.486 ' CG2' ' CB ' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 549' ' ' HIS . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 25.2 m-80 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.586 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.485 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.485 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.452 ' HG3' HG21 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.577 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.476 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.626 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.405 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.626 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.587 ' O ' HG12 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' A' ' 534' ' ' TYR . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.546 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 549' ' ' HIS . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 560' ' ' GLN . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 510' ' ' LYS . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.467 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.467 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 16.3 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.639 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.454 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.562 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 543' ' ' TYR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.662 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.43 ' CZ ' ' HB ' ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.482 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.482 ' HG3' ' C ' ' A' ' 544' ' ' ILE . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.402 ' CE ' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 549' ' ' HIS . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.52 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.639 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.462 ' HG3' HG22 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.8 t-20 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.587 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.648 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.648 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 544' ' ' ILE . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.432 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.568 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 15.5 m120 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.42 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.423 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 510' ' ' LYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.6 t-20 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.6 p30 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.408 HD22 ' ND2' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 523' ' ' GLU . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.587 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.414 ' O ' ' CZ2' ' A' ' 531' ' ' TRP . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.548 ' O ' HG21 ' A' ' 532' ' ' ILE . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.414 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 534' ' ' TYR . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.472 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.514 ' CG2' ' CB ' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.413 ' CA ' ' HA2' ' A' ' 536' ' ' GLY . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.479 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.578 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.54 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.564 ' HA ' ' CA ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.44 ' C ' ' CD2' ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.606 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.622 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.622 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.622 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . . . . . . . . . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.43 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 540' ' ' GLU . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 543' ' ' TYR . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.476 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE1' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.481 ' C ' ' H ' ' A' ' 551' ' ' GLN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.505 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 7.4 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.469 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.606 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.423 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.8 mm-40 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.575 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.654 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.62 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.59 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.429 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.453 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 529' ' ' LEU . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.519 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.467 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.575 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.654 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.606 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t-20 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.703 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.405 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.493 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.521 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 546' ' ' GLY . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.607 ' N ' ' O ' ' A' ' 546' ' ' GLY . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 551' ' ' GLN . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 32.0 m-80 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.703 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.46 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.573 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.476 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.476 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 7.3 mm-40 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 3.2 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.534 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.593 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.586 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.5 OUTLIER -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.586 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.632 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.632 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.424 HD21 ' CE1' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.416 ' CA ' HG23 ' A' ' 544' ' ' ILE . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.452 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.442 ' CG ' HD13 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.428 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.465 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.428 ' CA ' ' HA2' ' A' ' 536' ' ' GLY . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.532 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.572 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.49 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.49 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 4.4 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.607 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.406 HD22 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.607 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.649 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.404 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.498 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.465 ' CG1' ' CZ ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.465 ' CZ ' ' CG1' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.506 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.42 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.551 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.607 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.533 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . 0.424 ' O ' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.494 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 515' ' ' LEU . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.532 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.679 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.429 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.679 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.427 ' CB ' HG22 ' A' ' 532' ' ' ILE . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 529' ' ' LEU . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.457 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 524' ' ' GLY . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 508' ' ' GLN . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.492 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 13.6 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.529 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.413 HD21 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.406 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.66 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.405 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.66 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 532' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.656 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.656 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 532' ' ' ILE . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 530' ' ' ALA . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.578 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.538 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.609 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.581 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.402 ' CG2' ' H ' ' A' ' 520' ' ' THR . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 543' ' ' TYR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.618 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.618 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.513 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.513 ' HD1' ' CD2' ' A' ' 534' ' ' TYR . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.662 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.609 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.489 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.42 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.9 mm-40 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' HG22 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.408 ' HG2' ' O ' ' A' ' 509' ' ' PRO . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.495 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.51 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.593 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.3 OUTLIER -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.3 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 515' ' ' LEU . 6.4 t-160 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.608 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.602 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.404 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.602 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.495 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.587 ' O ' HG21 ' A' ' 532' ' ' ILE . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.506 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.506 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 33.8 m-80 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 507' ' ' ALA . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.442 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 1.5 pt20 -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.617 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.613 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.639 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.486 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.466 ' HB ' ' CE1' ' A' ' 543' ' ' TYR . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.473 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.473 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.524 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.617 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.502 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.423 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.617 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.1 t-20 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.548 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.672 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.672 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.457 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.476 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.443 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.476 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 546' ' ' GLY . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 31.2 m-80 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.538 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.617 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.538 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.649 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 2.5 t-20 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.41 ' CD2' ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.572 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.676 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.676 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.448 ' CZ ' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 532' ' ' ILE . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.586 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.553 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.595 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.528 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.524 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.857 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.9 t-20 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.857 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.483 ' O ' ' CG2' ' A' ' 519' ' ' THR . 0.8 OUTLIER 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.525 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 525' ' ' ALA . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.637 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 519' ' ' THR . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 532' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 534' ' ' TYR . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.459 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.576 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.44 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.44 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.591 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.572 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.645 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.436 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.498 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 549' ' ' HIS . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.591 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.543 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.411 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.2 mm-40 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 516' ' ' HIS . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HB2' ' ND2' ' A' ' 512' ' ' ASN . 0.6 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.433 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 520' ' ' THR . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 524' ' ' GLY . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 550' ' ' ASN . 2.8 tp60 -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.401 ' N ' HD12 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.491 HD11 ' CD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.451 ' CG2' ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 544' ' ' ILE . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 6.3 m120 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.48 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.697 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.6 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.6 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.0 t-20 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 513' ' ' PRO . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 523' ' ' GLU . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.414 ' O ' ' CG1' ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.415 ' O ' ' CZ2' ' A' ' 531' ' ' TRP . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.415 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.486 ' CG2' ' CB ' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 549' ' ' HIS . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 25.2 m-80 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.586 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.485 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.485 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.452 ' HG3' HG21 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.577 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.476 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.626 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.405 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.626 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.587 ' O ' HG12 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' A' ' 534' ' ' TYR . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.546 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 549' ' ' HIS . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 560' ' ' GLN . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 510' ' ' LYS . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.467 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.467 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 16.3 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.47 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.639 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.454 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.562 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 543' ' ' TYR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.662 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.43 ' CZ ' ' HB ' ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.482 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.482 ' HG3' ' C ' ' A' ' 544' ' ' ILE . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.565 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.402 ' CE ' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 549' ' ' HIS . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.52 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.639 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.462 ' HG3' HG22 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.69 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.8 t-20 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.587 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.648 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.648 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.423 ' CB ' HG23 ' A' ' 544' ' ' ILE . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.432 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.568 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 15.5 m120 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.42 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.423 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 510' ' ' LYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.6 t-20 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.6 p30 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.408 HD22 ' ND2' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 523' ' ' GLU . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.587 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 519' ' ' THR . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.414 ' O ' ' CZ2' ' A' ' 531' ' ' TRP . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.548 ' O ' HG21 ' A' ' 532' ' ' ILE . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.414 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 534' ' ' TYR . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.472 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.514 ' CG2' ' CB ' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.413 ' CA ' ' HA2' ' A' ' 536' ' ' GLY . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.479 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.578 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.54 ' CD1' ' HB3' ' A' ' 513' ' ' PRO . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.564 ' HA ' ' CA ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.44 ' C ' ' CD2' ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.606 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.622 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.622 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.622 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . . . . . . . . . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.43 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 540' ' ' GLU . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 543' ' ' TYR . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.476 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE1' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.481 ' C ' ' H ' ' A' ' 551' ' ' GLN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.505 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 7.4 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.469 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.606 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.423 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.8 mm-40 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.575 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.654 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.62 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.59 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.429 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.453 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.458 ' CZ ' ' CD1' ' A' ' 529' ' ' LEU . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.519 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.467 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.575 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.654 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.606 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t-20 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.703 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.405 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 529' ' ' LEU . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.493 ' C ' ' HG3' ' A' ' 545' ' ' GLU . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.521 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 546' ' ' GLY . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.607 ' N ' ' O ' ' A' ' 546' ' ' GLY . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 551' ' ' GLN . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 32.0 m-80 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.703 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.46 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.573 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.476 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.476 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 7.3 mm-40 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 3.2 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.534 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.593 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.586 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.5 OUTLIER -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.586 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.632 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.632 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.424 HD21 ' CE1' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.416 ' CA ' HG23 ' A' ' 544' ' ' ILE . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.452 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.442 ' CG ' HD13 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.428 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.465 ' O ' ' CD2' ' A' ' 547' ' ' LEU . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.428 ' CA ' ' HA2' ' A' ' 536' ' ' GLY . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.532 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.572 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.49 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.49 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 4.4 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.607 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.406 HD22 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.607 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.649 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.404 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.498 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.465 ' CG1' ' CZ ' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.465 ' CZ ' ' CG1' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.498 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.506 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.42 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.551 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.607 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.533 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.424 ' O ' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.494 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 515' ' ' LEU . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.532 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.679 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.429 ' O ' ' CG1' ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.679 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.427 ' CB ' HG22 ' A' ' 532' ' ' ILE . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 529' ' ' LEU . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.457 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 524' ' ' GLY . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 508' ' ' GLN . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.492 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 13.6 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.529 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.413 HD21 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.406 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.546 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.66 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.405 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.66 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 532' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.656 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.656 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 532' ' ' ILE . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 530' ' ' ALA . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 549' ' ' HIS . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.578 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.489 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 510' ' ' LYS . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.538 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.609 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.581 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.402 ' CG2' ' H ' ' A' ' 520' ' ' THR . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 543' ' ' TYR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.618 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.618 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 544' ' ' ILE . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.513 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.513 ' HD1' ' CD2' ' A' ' 534' ' ' TYR . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.662 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 540' ' ' GLU . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.609 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.489 ' O ' ' CD2' ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.42 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.9 mm-40 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 19.2 t-20 -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.911 ' HB3' HD12 ' A' ' 555' ' ' ILE . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 519' ' ' THR . 9.1 t60 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.634 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.569 ' H ' HG23 ' A' ' 519' ' ' THR . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.641 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.623 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.605 ' CG ' HG21 ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.941 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.605 HG21 ' CG ' ' A' ' 529' ' ' LEU . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.776 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.941 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.805 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.477 ' H ' HD12 ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 16.9 m120 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.494 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.574 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 558' ' ' LEU . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.495 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.3 mm100 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.634 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.642 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 42.6 t30 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.632 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.912 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.516 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 532' ' ' ILE . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.746 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.746 HD11 ' HB1' ' A' ' 539' ' ' ALA . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.591 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.912 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 555' ' ' ILE . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.634 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.963 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.7 mm100 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.636 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 41.0 t30 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.589 ' H ' HG23 ' A' ' 519' ' ' THR . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.74 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.466 ' CE1' HG13 ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.411 ' ND2' ' OE1' ' A' ' 521' ' ' GLN . 16.2 m120 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.567 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 555' ' ' ILE . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.636 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.014 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.014 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.679 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.2 t30 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.739 ' HD2' HD23 ' A' ' 515' ' ' LEU . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.739 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.715 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.568 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 519' ' ' THR . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.795 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.422 ' CB ' HE21 ' A' ' 521' ' ' GLN . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.701 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.795 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.54 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.701 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 528' ' ' GLY . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.668 ' CD1' HD23 ' A' ' 529' ' ' LEU . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 529' ' ' LEU . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.86 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.73 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.915 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.587 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 554' ' ' LEU . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.608 HD21 ' OD1' ' A' ' 552' ' ' ASP . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.612 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.996 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.996 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.669 ' HG3' HG23 ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.497 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.693 ' HB2' HG22 ' A' ' 555' ' ' ILE . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.875 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 51.4 t30 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 1.057 ' HB3' HD12 ' A' ' 555' ' ' ILE . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.551 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.808 ' O ' HG22 ' A' ' 519' ' ' THR . 2.3 t60 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.914 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.633 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.914 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.454 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.823 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.833 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.657 ' HZ ' HD13 ' A' ' 544' ' ' ILE . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.823 HG21 ' O ' ' A' ' 529' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 2.9 m-20 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 1.057 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.981 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.608 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 7.9 t-20 -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.69 ' O ' HG22 ' A' ' 519' ' ' THR . 0.3 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.625 HG21 ' O ' ' A' ' 543' ' ' TYR . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.824 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.544 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.625 ' O ' HG21 ' A' ' 520' ' ' THR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.69 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.69 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.475 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 3.7 m-20 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.549 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 555' ' ' ILE . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.608 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.015 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.015 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.3 mm100 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 3.8 t-20 -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.696 ' HB3' HD12 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 515' ' ' LEU . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 516' ' ' HIS . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.587 ' N ' HG23 ' A' ' 519' ' ' THR . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.601 ' CA ' HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.601 HD11 ' CA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.481 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.005 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.483 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.483 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 21.9 m-20 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.746 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 558' ' ' LEU . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.716 HG21 ' HB2' ' A' ' 510' ' ' LYS . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 557' ' ' GLY . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 42.6 t30 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' A' ' 556' ' ' CYS . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.554 ' H ' HG23 ' A' ' 519' ' ' THR . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.608 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.773 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.904 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.682 HG21 ' HG ' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.902 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.904 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.773 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.472 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.429 ' ND2' ' OE1' ' A' ' 521' ' ' GLN . 14.3 m120 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 555' ' ' ILE . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.605 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 507' ' ' ALA . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 6.1 t-20 -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.833 ' HB3' HD12 ' A' ' 555' ' ' ILE . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.582 ' H ' HG23 ' A' ' 519' ' ' THR . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.45 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.767 ' C ' HD12 ' A' ' 529' ' ' LEU . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 528' ' ' GLY . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.449 ' HD1' HG23 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.725 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' A' ' 532' ' ' ILE . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 535' ' ' PHE . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.619 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 543' ' ' TYR . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.574 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.605 ' OD2' HD21 ' A' ' 554' ' ' LEU . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.605 HD21 ' OD2' ' A' ' 552' ' ' ASP . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.749 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.439 ' CG ' ' HA3' ' A' ' 553' ' ' GLY . 5.2 mm100 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.589 ' HG3' HG23 ' A' ' 555' ' ' ILE . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.659 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 44.3 t30 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.834 ' HB3' HD12 ' A' ' 555' ' ' ILE . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.587 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.64 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.624 ' HB3' HG23 ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CD1' HG22 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.64 ' CZ ' HD13 ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.004 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 520' ' ' THR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.64 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.457 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.454 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.659 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.01 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.01 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.678 ' HG3' HG23 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.756 ' HB2' HG22 ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.726 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 44.6 t30 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.888 ' HB3' HD12 ' A' ' 555' ' ' ILE . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.617 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.617 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.585 ' H ' HG23 ' A' ' 519' ' ' THR . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.655 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 528' ' ' GLY . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.405 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.634 HG21 ' HG ' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.921 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.626 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 69.9 m-20 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.425 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.888 HD12 ' HB3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.942 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.942 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.774 ' HG3' HG23 ' A' ' 555' ' ' ILE . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.763 ' HB2' HG22 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 556' ' ' CYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 38.3 t30 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.719 ' O ' HD13 ' A' ' 515' ' ' LEU . 1.4 p-10 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.616 ' O ' HG22 ' A' ' 519' ' ' THR . 1.3 t-80 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.547 ' H ' HG23 ' A' ' 519' ' ' THR . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.432 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.821 ' C ' HD23 ' A' ' 529' ' ' LEU . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 528' ' ' GLY . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.893 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 529' ' ' LEU . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.408 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.92 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.422 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.92 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.893 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.449 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.596 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 508' ' ' GLN . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.583 ' HA ' ' N ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.917 ' C ' HD23 ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.917 HD23 ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 9.0 t-20 -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.645 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.645 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 519' ' ' THR . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.661 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.664 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 547' ' ' LEU . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.495 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 544' ' ' ILE . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 532' ' ' ILE . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.897 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.897 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.607 ' CA ' HD12 ' A' ' 542' ' ' ILE . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.607 HD12 ' CA ' ' A' ' 539' ' ' ALA . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.52 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 529' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 525' ' ' ALA . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 4.5 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.558 ' HB2' HD13 ' A' ' 555' ' ' ILE . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.969 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.7 mm100 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 555' ' ' ILE . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.603 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.8 t30 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.812 ' HB3' HD12 ' A' ' 555' ' ' ILE . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.622 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.612 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 543' ' ' TYR . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.461 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.739 ' HB2' HD11 ' A' ' 532' ' ' ILE . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 520' ' ' THR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.592 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.434 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 2.8 m-20 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.025 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.025 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.1 mm100 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.439 ' HG3' HG23 ' A' ' 555' ' ' ILE . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.612 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 43.2 t30 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.583 ' H ' HG23 ' A' ' 519' ' ' THR . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.694 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.694 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.444 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 532' ' ' ILE . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.805 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.555 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.759 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.66 ' H ' HD12 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 16.0 m120 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.514 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.611 ' HB2' HD13 ' A' ' 555' ' ' ILE . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.468 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 3.5 mm100 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 5.5 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.549 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.617 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 31.6 t-20 -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.1 p-10 -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.617 ' O ' HG22 ' A' ' 519' ' ' THR . 12.8 t60 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 519' ' ' THR . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.67 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.484 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 528' ' ' GLY . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.435 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.799 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.795 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.451 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 555' ' ' ILE . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.468 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 2.6 mm100 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.513 ' HD2' HG21 ' A' ' 555' ' ' ILE . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 7.6 t-20 -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.638 ' O ' HG22 ' A' ' 519' ' ' THR . 0.5 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.629 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.607 ' H ' HG23 ' A' ' 519' ' ' THR . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.69 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.605 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 544' ' ' ILE . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 544' ' ' ILE . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 531' ' ' TRP . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.476 ' HE1' HD12 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 535' ' ' PHE . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 525' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.506 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.782 ' HG ' HG22 ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.506 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.582 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 555' ' ' ILE . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.008 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 4.5 mm100 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.496 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.552 ' HB2' HG21 ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.876 ' HB3' HD12 ' A' ' 555' ' ' ILE . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.584 ' H ' HG23 ' A' ' 519' ' ' THR . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.66 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 528' ' ' GLY . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.411 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 532' ' ' ILE . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.871 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.521 ' CE2' HG22 ' A' ' 542' ' ' ILE . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.818 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.406 ' C ' ' HG ' ' A' ' 547' ' ' LEU . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.527 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 3.2 m-20 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.54 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.876 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.761 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.491 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.0 mm100 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLN . . . . . 0.645 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.634 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 44.2 t30 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 555' ' ' ILE . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.548 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.552 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.573 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.77 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.737 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.696 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.696 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 529' ' ' LEU . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.887 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.409 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 1.011 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 4.7 mm100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.637 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.1 t30 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.621 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.586 ' H ' HG23 ' A' ' 519' ' ' THR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.683 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.693 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 528' ' ' GLY . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.522 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.683 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.578 ' H ' ' HB3' ' A' ' 539' ' ' ALA . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' A' ' 555' ' ' ILE . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.626 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.949 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.428 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.7 mm100 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 19.2 t-20 -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.911 ' HB3' HD12 ' A' ' 555' ' ' ILE . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 519' ' ' THR . 9.1 t60 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.634 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.569 ' H ' HG23 ' A' ' 519' ' ' THR . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.641 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.623 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.605 ' CG ' HG21 ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.941 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.605 HG21 ' CG ' ' A' ' 529' ' ' LEU . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.776 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.941 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.805 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.477 ' H ' HD12 ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 16.9 m120 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.494 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.574 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 558' ' ' LEU . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.495 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.3 mm100 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.634 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.642 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 42.6 t30 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.632 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.912 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.516 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 532' ' ' ILE . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.746 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.746 HD11 ' HB1' ' A' ' 539' ' ' ALA . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.591 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.912 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 555' ' ' ILE . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.634 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.963 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.7 mm100 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.636 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 41.0 t30 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.589 ' H ' HG23 ' A' ' 519' ' ' THR . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.74 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.466 ' CE1' HG13 ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.411 ' ND2' ' OE1' ' A' ' 521' ' ' GLN . 16.2 m120 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.567 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 555' ' ' ILE . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.636 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.014 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.014 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.679 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.2 t30 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.739 ' HD2' HD23 ' A' ' 515' ' ' LEU . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.739 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.715 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.568 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 519' ' ' THR . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.795 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.422 ' CB ' HE21 ' A' ' 521' ' ' GLN . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.701 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.795 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.54 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.701 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 528' ' ' GLY . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.668 ' CD1' HD23 ' A' ' 529' ' ' LEU . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 529' ' ' LEU . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.86 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.73 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.915 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.587 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 554' ' ' LEU . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.608 HD21 ' OD1' ' A' ' 552' ' ' ASP . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.612 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.996 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.996 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.669 ' HG3' HG23 ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.497 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.693 ' HB2' HG22 ' A' ' 555' ' ' ILE . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.875 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 51.4 t30 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 1.057 ' HB3' HD12 ' A' ' 555' ' ' ILE . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.551 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.808 ' O ' HG22 ' A' ' 519' ' ' THR . 2.3 t60 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.914 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.633 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.914 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.454 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.823 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.833 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.657 ' HZ ' HD13 ' A' ' 544' ' ' ILE . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.823 HG21 ' O ' ' A' ' 529' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 2.9 m-20 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 1.057 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.981 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.608 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 7.9 t-20 -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.69 ' O ' HG22 ' A' ' 519' ' ' THR . 0.3 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.625 HG21 ' O ' ' A' ' 543' ' ' TYR . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.824 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.544 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.625 ' O ' HG21 ' A' ' 520' ' ' THR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.69 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.69 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.475 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 3.7 m-20 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.549 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 555' ' ' ILE . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.608 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.015 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.015 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.3 mm100 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 3.8 t-20 -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.696 ' HB3' HD12 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 515' ' ' LEU . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 516' ' ' HIS . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.587 ' N ' HG23 ' A' ' 519' ' ' THR . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.601 ' CA ' HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.601 HD11 ' CA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.481 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.005 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.483 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.483 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 21.9 m-20 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.746 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 558' ' ' LEU . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.716 HG21 ' HB2' ' A' ' 510' ' ' LYS . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 557' ' ' GLY . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 42.6 t30 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' A' ' 556' ' ' CYS . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.554 ' H ' HG23 ' A' ' 519' ' ' THR . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.608 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.773 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.904 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.682 HG21 ' HG ' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.902 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.904 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.773 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.472 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.429 ' ND2' ' OE1' ' A' ' 521' ' ' GLN . 14.3 m120 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 555' ' ' ILE . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.605 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 507' ' ' ALA . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 6.1 t-20 -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.833 ' HB3' HD12 ' A' ' 555' ' ' ILE . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.582 ' H ' HG23 ' A' ' 519' ' ' THR . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.45 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.767 ' C ' HD12 ' A' ' 529' ' ' LEU . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 528' ' ' GLY . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.449 ' HD1' HG23 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.725 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' A' ' 532' ' ' ILE . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 535' ' ' PHE . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.619 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 543' ' ' TYR . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.574 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.605 ' OD2' HD21 ' A' ' 554' ' ' LEU . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.605 HD21 ' OD2' ' A' ' 552' ' ' ASP . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.749 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.439 ' CG ' ' HA3' ' A' ' 553' ' ' GLY . 5.2 mm100 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.589 ' HG3' HG23 ' A' ' 555' ' ' ILE . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.659 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 44.3 t30 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.834 ' HB3' HD12 ' A' ' 555' ' ' ILE . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.587 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.64 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.624 ' HB3' HG23 ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CD1' HG22 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.64 ' CZ ' HD13 ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.004 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 520' ' ' THR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.64 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.457 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.454 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.659 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.01 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.01 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.678 ' HG3' HG23 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.756 ' HB2' HG22 ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.726 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 44.6 t30 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.888 ' HB3' HD12 ' A' ' 555' ' ' ILE . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.617 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.617 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.585 ' H ' HG23 ' A' ' 519' ' ' THR . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.655 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 528' ' ' GLY . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.405 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.634 HG21 ' HG ' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.921 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.626 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 69.9 m-20 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.425 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.888 HD12 ' HB3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.942 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.942 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.774 ' HG3' HG23 ' A' ' 555' ' ' ILE . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.763 ' HB2' HG22 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 556' ' ' CYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 38.3 t30 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.719 ' O ' HD13 ' A' ' 515' ' ' LEU . 1.4 p-10 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.616 ' O ' HG22 ' A' ' 519' ' ' THR . 1.3 t-80 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.547 ' H ' HG23 ' A' ' 519' ' ' THR . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.432 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.821 ' C ' HD23 ' A' ' 529' ' ' LEU . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 528' ' ' GLY . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.893 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 529' ' ' LEU . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.408 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.92 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.422 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.92 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.893 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.449 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.596 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 508' ' ' GLN . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.583 ' HA ' ' N ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.917 ' C ' HD23 ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.917 HD23 ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 9.0 t-20 -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.645 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 519' ' ' THR . 0.2 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.645 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 519' ' ' THR . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.661 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.664 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 547' ' ' LEU . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.495 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 544' ' ' ILE . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 532' ' ' ILE . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.897 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.897 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.607 ' CA ' HD12 ' A' ' 542' ' ' ILE . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.607 HD12 ' CA ' ' A' ' 539' ' ' ALA . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.52 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 529' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 525' ' ' ALA . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 4.5 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.558 ' HB2' HD13 ' A' ' 555' ' ' ILE . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.969 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.7 mm100 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 555' ' ' ILE . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.603 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.8 t30 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.812 ' HB3' HD12 ' A' ' 555' ' ' ILE . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.622 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.612 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 543' ' ' TYR . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.461 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.739 ' HB2' HD11 ' A' ' 532' ' ' ILE . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 520' ' ' THR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.592 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.434 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 2.8 m-20 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.025 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.025 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.1 mm100 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.439 ' HG3' HG23 ' A' ' 555' ' ' ILE . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.612 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 43.2 t30 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.583 ' H ' HG23 ' A' ' 519' ' ' THR . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.694 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.694 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.444 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 532' ' ' ILE . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.805 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.555 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.759 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.66 ' H ' HD12 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 16.0 m120 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.514 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.611 ' HB2' HD13 ' A' ' 555' ' ' ILE . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.468 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 3.5 mm100 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 5.5 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.549 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.617 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 31.6 t-20 -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.1 p-10 -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.617 ' O ' HG22 ' A' ' 519' ' ' THR . 12.8 t60 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 519' ' ' THR . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.67 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.484 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 528' ' ' GLY . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.435 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.799 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.795 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.451 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 555' ' ' ILE . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.468 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 2.6 mm100 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.513 ' HD2' HG21 ' A' ' 555' ' ' ILE . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 7.6 t-20 -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.638 ' O ' HG22 ' A' ' 519' ' ' THR . 0.5 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.629 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.607 ' H ' HG23 ' A' ' 519' ' ' THR . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.69 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.605 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 544' ' ' ILE . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 544' ' ' ILE . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 531' ' ' TRP . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.476 ' HE1' HD12 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 535' ' ' PHE . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 525' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.506 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.782 ' HG ' HG22 ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.506 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.582 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 555' ' ' ILE . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.008 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 4.5 mm100 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.496 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.552 ' HB2' HG21 ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.876 ' HB3' HD12 ' A' ' 555' ' ' ILE . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.584 ' H ' HG23 ' A' ' 519' ' ' THR . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.66 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 528' ' ' GLY . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.411 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 532' ' ' ILE . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.871 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.521 ' CE2' HG22 ' A' ' 542' ' ' ILE . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.818 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.406 ' C ' ' HG ' ' A' ' 547' ' ' LEU . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.527 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 3.2 m-20 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.54 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.876 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.761 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.491 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.0 mm100 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.645 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.634 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 44.2 t30 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 555' ' ' ILE . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.548 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.552 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.573 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.77 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.737 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.696 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.696 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 529' ' ' LEU . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.887 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.409 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 1.011 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 4.7 mm100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.637 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 40.1 t30 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.621 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.586 ' H ' HG23 ' A' ' 519' ' ' THR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.683 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.693 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 528' ' ' GLY . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.522 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.683 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.578 ' H ' ' HB3' ' A' ' 539' ' ' ALA . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' A' ' 555' ' ' ILE . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.626 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.949 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.428 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.7 mm100 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.3 OUTLIER -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.911 ' HB3' HD12 ' A' ' 555' ' ' ILE . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.3 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 519' ' ' THR . 6.4 t-160 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.634 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.569 ' H ' HG23 ' A' ' 519' ' ' THR . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.641 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.623 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.605 ' CG ' HG21 ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.941 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.605 HG21 ' CG ' ' A' ' 529' ' ' LEU . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.776 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.941 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.805 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.477 ' H ' HD12 ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 33.8 m-80 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.494 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.574 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 558' ' ' LEU . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.495 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 1.5 pt20 -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.634 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.642 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.632 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.912 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.516 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 532' ' ' ILE . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.746 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.746 HD11 ' HB1' ' A' ' 539' ' ' ALA . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.591 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.912 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 555' ' ' ILE . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.634 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.963 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.636 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.1 t-20 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.589 ' H ' HG23 ' A' ' 519' ' ' THR . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.74 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.466 ' CE1' HG13 ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.567 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 555' ' ' ILE . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.636 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.014 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.014 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.679 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 2.5 t-20 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.739 ' HD2' HD23 ' A' ' 515' ' ' LEU . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.739 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.715 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.568 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 519' ' ' THR . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.795 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.422 ' CB ' HE21 ' A' ' 521' ' ' GLN . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.701 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.795 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.54 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.701 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 528' ' ' GLY . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.668 ' CD1' HD23 ' A' ' 529' ' ' LEU . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 529' ' ' LEU . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.86 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.73 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.915 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.587 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 554' ' ' LEU . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.608 HD21 ' OD1' ' A' ' 552' ' ' ASP . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.612 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.996 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.996 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.669 ' HG3' HG23 ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.497 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.693 ' HB2' HG22 ' A' ' 555' ' ' ILE . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.875 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.9 t-20 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 1.057 ' HB3' HD12 ' A' ' 555' ' ' ILE . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.551 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.808 ' O ' HG22 ' A' ' 519' ' ' THR . 0.8 OUTLIER 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.914 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.633 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.914 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.454 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.823 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.833 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.657 ' HZ ' HD13 ' A' ' 544' ' ' ILE . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.823 HG21 ' O ' ' A' ' 529' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 1.057 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.981 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.608 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.69 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.625 HG21 ' O ' ' A' ' 543' ' ' TYR . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.824 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.544 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.625 ' O ' HG21 ' A' ' 520' ' ' THR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.69 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.69 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.475 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.549 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 555' ' ' ILE . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.608 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.015 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.015 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.2 mm-40 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.696 ' HB3' HD12 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 515' ' ' LEU . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 516' ' ' HIS . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.587 ' N ' HG23 ' A' ' 519' ' ' THR . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 2.8 tp60 -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.601 ' CA ' HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.601 HD11 ' CA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.481 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.005 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.483 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.483 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 6.3 m120 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.746 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 558' ' ' LEU . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.716 HG21 ' HB2' ' A' ' 510' ' ' LYS . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 557' ' ' GLY . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.61 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.0 t-20 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' A' ' 556' ' ' CYS . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.554 ' H ' HG23 ' A' ' 519' ' ' THR . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.608 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.773 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.904 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.682 HG21 ' HG ' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.902 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.904 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.773 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.472 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 25.2 m-80 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 555' ' ' ILE . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.605 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 507' ' ' ALA . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.504 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.833 ' HB3' HD12 ' A' ' 555' ' ' ILE . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.582 ' H ' HG23 ' A' ' 519' ' ' THR . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.45 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.767 ' C ' HD12 ' A' ' 529' ' ' LEU . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 528' ' ' GLY . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.449 ' HD1' HG23 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.725 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' A' ' 532' ' ' ILE . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 535' ' ' PHE . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.619 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 543' ' ' TYR . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.574 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.605 ' OD2' HD21 ' A' ' 554' ' ' LEU . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.605 HD21 ' OD2' ' A' ' 552' ' ' ASP . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.749 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.477 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 16.3 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.589 ' HG3' HG23 ' A' ' 555' ' ' ILE . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.659 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.834 ' HB3' HD12 ' A' ' 555' ' ' ILE . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.587 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.64 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.624 ' HB3' HG23 ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CD1' HG22 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.64 ' CZ ' HD13 ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.004 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 520' ' ' THR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.64 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.457 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.454 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.659 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.01 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.01 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.678 ' HG3' HG23 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.756 ' HB2' HG22 ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.726 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.8 t-20 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.888 ' HB3' HD12 ' A' ' 555' ' ' ILE . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.617 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.617 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.585 ' H ' HG23 ' A' ' 519' ' ' THR . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.655 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 528' ' ' GLY . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.405 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.634 HG21 ' HG ' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.921 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.626 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 15.5 m120 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.425 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.888 HD12 ' HB3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.942 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.942 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.774 ' HG3' HG23 ' A' ' 555' ' ' ILE . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.763 ' HB2' HG22 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 556' ' ' CYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.6 t-20 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.719 ' O ' HD13 ' A' ' 515' ' ' LEU . 1.6 p30 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.616 ' O ' HG22 ' A' ' 519' ' ' THR . 4.0 t-160 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.547 ' H ' HG23 ' A' ' 519' ' ' THR . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.432 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.821 ' C ' HD23 ' A' ' 529' ' ' LEU . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 528' ' ' GLY . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.893 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 529' ' ' LEU . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.408 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.92 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.422 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.92 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.893 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.449 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.596 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 508' ' ' GLN . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.583 ' HA ' ' N ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.917 ' C ' HD23 ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.917 HD23 ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.645 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.645 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 519' ' ' THR . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.661 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.664 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 547' ' ' LEU . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.495 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 544' ' ' ILE . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 532' ' ' ILE . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.897 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.897 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.607 ' CA ' HD12 ' A' ' 542' ' ' ILE . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.607 HD12 ' CA ' ' A' ' 539' ' ' ALA . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.52 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 529' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 525' ' ' ALA . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 7.4 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.558 ' HB2' HD13 ' A' ' 555' ' ' ILE . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.969 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.8 mm-40 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 555' ' ' ILE . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.603 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.812 ' HB3' HD12 ' A' ' 555' ' ' ILE . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.622 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.612 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 543' ' ' TYR . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.461 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.739 ' HB2' HD11 ' A' ' 532' ' ' ILE . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 520' ' ' THR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.592 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.434 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.025 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.025 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.0 mm-40 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.439 ' HG3' HG23 ' A' ' 555' ' ' ILE . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.612 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.7 t-20 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.583 ' H ' HG23 ' A' ' 519' ' ' THR . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.694 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.694 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.444 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 532' ' ' ILE . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.805 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.555 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.759 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.66 ' H ' HD12 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.514 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.611 ' HB2' HD13 ' A' ' 555' ' ' ILE . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.491 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.491 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 7.3 mm-40 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 3.2 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.549 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.617 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.5 OUTLIER -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.617 ' O ' HG22 ' A' ' 519' ' ' THR . 8.4 t-160 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 519' ' ' THR . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.67 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.484 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 528' ' ' GLY . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.435 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.799 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.795 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.451 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 555' ' ' ILE . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.508 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . 0.407 ' H ' HE21 ' A' ' 560' ' ' GLN . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.508 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 4.4 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.513 ' HD2' HG21 ' A' ' 555' ' ' ILE . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.638 ' O ' HG22 ' A' ' 519' ' ' THR . 0.3 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.629 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.607 ' H ' HG23 ' A' ' 519' ' ' THR . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.69 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.605 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 544' ' ' ILE . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 544' ' ' ILE . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 531' ' ' TRP . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.476 ' HE1' HD12 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 535' ' ' PHE . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 525' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.506 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.782 ' HG ' HG22 ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.506 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.582 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 555' ' ' ILE . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.008 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 4.7 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.496 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.552 ' HB2' HG21 ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.876 ' HB3' HD12 ' A' ' 555' ' ' ILE . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.584 ' H ' HG23 ' A' ' 519' ' ' THR . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.66 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 528' ' ' GLY . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.411 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 532' ' ' ILE . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.871 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.521 ' CE2' HG22 ' A' ' 542' ' ' ILE . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.818 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.406 ' C ' ' HG ' ' A' ' 547' ' ' LEU . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.527 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.54 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.876 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.761 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.491 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 13.6 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . 0.645 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.634 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 555' ' ' ILE . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.548 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.552 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.573 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.77 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.737 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.696 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.696 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 529' ' ' LEU . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.887 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.409 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 1.011 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.637 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.621 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.586 ' H ' HG23 ' A' ' 519' ' ' THR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.683 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.693 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 528' ' ' GLY . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.522 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.683 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.578 ' H ' ' HB3' ' A' ' 539' ' ' ALA . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' A' ' 555' ' ' ILE . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.626 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.949 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.428 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.9 mm-40 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -176.65 122.66 0.29 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -98.05 101.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.544 2.829 . . . . 0.0 113.383 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.7 OUTLIER -152.27 -46.68 0.1 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.637 179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 75.6 42.31 0.23 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.052 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.3 OUTLIER -130.37 40.44 0.61 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.643 177.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.911 ' HB3' HD12 ' A' ' 555' ' ' ILE . 22.4 Cg_endo -87.03 -105.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.793 2.329 . . . . 0.0 112.911 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 0.3 OUTLIER -74.51 -1.46 21.43 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.3 mm? -96.35 41.06 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 110.949 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 519' ' ' THR . 6.4 t-160 176.21 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.634 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -38.18 -41.57 0.61 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.898 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.07 81.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.6 t -169.78 -55.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.569 ' H ' HG23 ' A' ' 519' ' ' THR . 4.9 t -125.14 -3.77 7.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.925 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.641 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.9 pp0? -95.44 -38.47 10.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.539 0.685 . . . . 0.0 109.992 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.79 3.24 48.92 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.47 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.623 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.51 -24.57 1.55 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.527 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.63 -28.93 2.18 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.416 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -101.97 21.47 14.68 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.338 0.59 . . . . 0.0 110.634 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.72 -3.91 1.26 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.11 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.59 -38.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.796 0.331 . . . . 0.0 110.998 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.73 -131.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.771 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.605 ' CG ' HG21 ' A' ' 532' ' ' ILE . 3.8 mp -126.29 74.0 1.42 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.941 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -102.28 -31.82 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.781 0.8 . . . . 0.0 109.847 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -19.76 62.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.364 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.605 HG21 ' CG ' ' A' ' 529' ' ' LEU . 3.4 tt -90.63 113.19 56.92 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.412 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.99 60.17 7.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.522 2.148 . . . . 0.0 112.32 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -100.67 -50.37 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.776 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -116.16 -40.26 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.285 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 49.83 -104.45 0.11 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.69 -8.18 10.7 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 113.008 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -81.58 -17.63 47.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.097 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.12 -3.6 34.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.0 mt-10 -57.58 84.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.694 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . 133.06 -14.07 4.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.274 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -101.75 -27.13 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.093 0.447 . . . . 0.0 111.934 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.63 -95.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.941 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.9 mp -68.34 -53.9 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 7.9 mt-10 79.71 -168.06 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.934 0.397 . . . . 0.0 110.882 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -111.58 52.13 0.65 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.905 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.805 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -82.16 -71.65 0.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.427 0.156 . . . . 0.0 111.398 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.477 ' H ' HD12 ' A' ' 547' ' ' LEU . 6.3 mtm 71.59 -23.03 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -84.77 -26.27 27.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 110.598 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 33.8 m-80 73.92 -25.4 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.909 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.494 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 47.1 mt-30 74.39 121.9 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 111.448 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.1 m-20 -154.02 58.51 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.245 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.98 48.23 49.29 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.538 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.76 -20.13 13.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.911 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mt -109.78 -45.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.574 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 3.4 t -68.22 -18.45 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.829 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 560' ' ' GLN . . . -164.62 115.87 0.67 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 558' ' ' LEU . 4.3 mp -72.08 -14.2 61.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.455 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.25 21.29 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.805 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.495 ' HG2' ' HA3' ' A' ' 557' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.878 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.447 ' HG3' ' CG2' ' A' ' 555' ' ' ILE . 1.5 pt20 -179.23 125.81 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -93.72 112.22 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.258 2.639 . . . . 0.0 112.837 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 1.7 mtmt -151.15 -49.51 0.12 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.011 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.634 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 76.8 43.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.229 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.642 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.26 37.39 0.38 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.838 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 46.4 Cg_endo -85.24 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.444 2.096 . . . . 0.0 113.085 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 8.8 p30 -79.43 5.8 11.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -100.03 40.64 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.416 0.626 . . . . 0.0 109.998 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 1.2 t-160 176.44 -32.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.632 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -38.73 -42.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.402 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 79.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.654 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.5 t -167.03 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 0.0 110.72 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 14.0 t -121.08 -8.17 9.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.935 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -100.2 -23.53 14.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.291 0.567 . . . . 0.0 110.42 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.74 3.03 20.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.2 mt-10 -138.68 -24.66 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.635 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -112.53 -24.62 4.94 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.069 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -106.75 20.61 18.77 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 121.251 0.548 . . . . 0.0 111.089 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -136.47 -3.87 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.571 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.08 -35.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.67 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -67.35 -126.0 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 18.7 mt -130.65 76.34 1.72 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.912 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -107.38 -30.62 8.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.674 0.75 . . . . 0.0 110.031 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.516 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -72.24 -7.77 51.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.128 179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 532' ' ' ILE . 9.6 tt -110.13 84.26 3.53 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.838 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 29.6 Cg_exo -61.03 79.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.551 2.167 . . . . 0.0 111.966 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -102.59 -56.31 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -120.62 -40.31 2.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 52.59 -116.08 4.96 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.867 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.0 -2.39 12.21 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.756 2.304 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.28 71.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.0 110.366 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.746 ' HB1' HD11 ' A' ' 542' ' ' ILE . . . -96.17 -42.86 8.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.362 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HG3' ' A' ' 545' ' ' GLU . 13.4 pt-20 32.16 96.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.616 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.72 -8.69 2.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.54 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.746 HD11 ' HB1' ' A' ' 539' ' ' ALA . 2.1 mt -87.42 -40.21 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.154 0.477 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.591 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 177.33 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.485 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.912 HG21 ' CB ' ' A' ' 530' ' ' ALA . 1.0 OUTLIER -61.93 -69.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 540' ' ' GLU . 2.6 mm-40 74.76 -133.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.346 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -86.17 -3.44 84.93 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.98 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.7 OUTLIER -76.44 123.13 25.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.321 0.582 . . . . 0.0 110.148 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' C ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -143.29 0.64 1.18 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.407 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -85.15 -20.77 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.298 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.0 m120 80.51 -23.42 0.23 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.8 mt-30 77.16 123.19 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.543 0.687 . . . . 0.0 111.472 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.1 OUTLIER -152.14 59.9 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.574 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 70.19 55.27 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.256 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' A' ' 555' ' ' ILE . 25.4 mt -106.52 -28.23 10.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 111.124 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.69 -29.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.8 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.634 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 0.9 OUTLIER -76.95 -9.51 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.993 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.963 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -160.26 -135.25 1.8 Allowed Glycine 0 N--CA 1.436 -1.303 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -153.35 -35.59 0.11 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.815 0.341 . . . . 0.0 110.887 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.84 33.1 4.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 1.8 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -179.48 129.21 0.25 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -90.68 116.38 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.127 2.551 . . . . 0.0 112.436 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 7.4 mmtt -157.65 -53.42 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.636 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 79.04 45.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.941 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.626 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.1 t-20 -133.96 34.69 0.26 Allowed Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.054 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 77.5 Cg_endo -81.2 -101.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.308 2.005 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 9.4 p30 -79.65 5.18 13.9 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.4 mm? -99.65 44.1 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.488 0.661 . . . . 0.0 109.904 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.48 -31.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.4 -42.61 0.75 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.86 78.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.348 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -166.93 -55.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.671 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.589 ' H ' HG23 ' A' ' 519' ' ' THR . 15.3 t -121.35 -2.89 9.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.689 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -100.65 -38.85 8.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.536 0.684 . . . . 0.0 110.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 1.5 57.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.667 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.6 mt-10 -136.4 -25.51 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.611 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -113.36 -25.79 4.23 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.32 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -107.66 24.55 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.236 0.541 . . . . 0.0 110.55 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -142.5 -2.54 1.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.188 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.46 -40.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.34 -108.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.74 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.6 OUTLIER -137.64 89.56 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.085 0.469 . . . . 0.0 112.073 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -120.38 -21.68 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.351 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -11.39 60.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.66 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -87.93 129.16 51.31 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -86.28 21.89 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.844 2.363 . . . . 0.0 113.773 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.466 ' CE1' HG13 ' A' ' 532' ' ' ILE . 4.5 p90 -120.28 -9.3 9.54 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -93.86 20.79 7.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 110.903 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 535' ' ' PHE . . . -54.16 -109.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.117 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.38 -3.31 13.47 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.625 2.217 . . . . 0.0 112.923 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.93 37.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.693 0.283 . . . . 0.0 111.741 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.08 -24.25 14.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mm-40 -29.67 91.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.257 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 125.89 -10.59 7.46 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.321 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.48 -33.65 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.382 0.591 . . . . 0.0 111.422 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 177.42 -98.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.866 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.8 mp -55.61 -68.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-O 120.72 0.295 . . . . 0.0 111.78 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.4 mt-10 79.75 16.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 74.21 -61.09 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.997 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.47 -77.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.252 0.621 . . . . 0.0 112.475 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.587 ' N ' ' O ' ' A' ' 546' ' ' GLY . 1.3 mtm 79.46 -24.85 0.2 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -88.93 -25.3 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.585 0.231 . . . . 0.0 111.013 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 68.8 -9.84 0.53 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.465 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.567 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.8 mt-30 71.37 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.495 0.664 . . . . 0.0 111.631 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.1 t70 -155.28 60.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 70.26 54.75 10.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.227 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 555' ' ' ILE . 29.6 mt -109.13 -30.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.44 -19.1 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.636 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -87.02 16.42 5.02 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 110.993 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.014 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 175.02 -128.19 1.38 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.014 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.62 -36.65 0.11 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.891 0.376 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.44 40.88 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.664 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.253 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -178.56 128.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.19 114.3 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.107 2.538 . . . . 0.0 112.391 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 5.5 mttm -153.96 -49.79 0.09 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.06 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 75.89 45.79 0.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.715 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.679 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 2.5 t-20 -131.59 35.34 0.29 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.772 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.739 ' HD2' HD23 ' A' ' 515' ' ' LEU . 51.3 Cg_endo -86.62 -102.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.364 2.043 . . . . 0.0 113.486 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 6.2 p30 -84.17 20.05 1.68 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.739 HD23 ' HD2' ' A' ' 513' ' ' PRO . 1.8 mm? -102.79 -19.62 14.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.383 . . . . 0.0 110.584 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.715 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER -130.19 -15.32 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.094 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.568 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 3.3 p90 -38.04 -51.66 1.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.793 0.33 . . . . 0.0 111.831 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.443 ' N ' ' CG ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -60.05 83.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 179.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 516' ' ' HIS . 6.9 t -177.23 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.251 0.548 . . . . 0.0 110.699 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 519' ' ' THR . 9.6 t -123.96 -0.04 8.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.446 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.795 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -101.2 -34.21 9.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.623 0.725 . . . . 0.0 110.173 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.422 ' CB ' HE21 ' A' ' 521' ' ' GLN . 0.5 OUTLIER -97.68 0.21 46.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.362 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.701 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.9 OUTLIER -134.9 -24.95 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.643 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -114.38 -26.2 3.79 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.562 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.795 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -107.89 23.58 14.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.346 0.594 . . . . 0.0 110.526 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.54 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.82 -2.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.701 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.33 -48.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 110.64 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -67.85 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.237 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 528' ' ' GLY . 2.9 mp -138.26 -174.3 3.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 111.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 529' ' ' LEU . . . 136.5 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.902 0.881 . . . . 0.0 109.333 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -13.73 61.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.527 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.668 ' CD1' HD23 ' A' ' 529' ' ' LEU . 0.2 OUTLIER -90.19 132.05 36.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -86.36 29.51 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.879 2.386 . . . . 0.0 113.77 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 11.6 p90 -134.47 4.55 3.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 529' ' ' LEU . 1.0 OUTLIER -93.56 20.38 7.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.449 0.166 . . . . 0.0 111.302 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -53.82 -102.23 0.01 OUTLIER Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.919 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.39 -2.72 12.92 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.624 2.216 . . . . 0.0 112.798 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -80.14 -28.26 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.428 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.93 -14.51 19.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 0.0 111.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 12.3 pt-20 -41.01 106.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.06 -7.22 54.59 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.777 -0.647 . . . . 0.0 114.461 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.86 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.6 mt -101.64 -34.85 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 117.466 0.633 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 179.54 -100.38 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.73 ' O ' HD23 ' A' ' 547' ' ' LEU . 1.5 mp -56.71 -70.36 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.858 0.361 . . . . 0.0 111.228 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.915 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 5.9 mt-10 79.45 34.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.58 64.32 Favored Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.555 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.8 OUTLIER -103.7 124.28 48.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.254 0.55 . . . . 0.0 110.273 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.63 1.53 2.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 9.2 m80 -94.64 -10.9 30.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.645 0.26 . . . . 0.0 110.517 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 3.0 m-80 69.06 -4.76 1.17 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.631 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.587 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.1 mt-30 69.82 122.8 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.633 0.73 . . . . 0.0 111.762 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 554' ' ' LEU . 11.4 p30 -150.85 60.02 0.93 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.795 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 69.02 55.67 10.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.221 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.608 HD21 ' OD1' ' A' ' 552' ' ' ASP . 21.7 mt -109.7 -28.45 8.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.229 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -109.9 -18.36 7.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.384 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.612 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.8 t -86.63 19.07 3.03 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 111.298 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.996 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 171.42 -127.3 1.41 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.996 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.3 OUTLIER -152.89 -38.49 0.1 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.858 0.361 . . . . 0.0 110.362 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -134.34 42.01 2.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.484 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.108 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.88 0.371 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.669 ' HG3' HG23 ' A' ' 555' ' ' ILE . 14.8 pt20 -177.37 119.92 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.497 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 19.1 Cg_endo -97.29 140.05 0.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.169 2.579 . . . . 0.0 112.568 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.693 ' HB2' HG22 ' A' ' 555' ' ' ILE . 4.5 mtpp -179.09 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.973 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 17.8 m 73.15 46.9 0.21 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.821 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.875 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.9 t-20 -129.82 29.14 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.723 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 1.057 ' HB3' HD12 ' A' ' 555' ' ' ILE . 18.1 Cg_endo -95.18 -81.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.626 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.551 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 3.5 p30 -83.31 5.06 24.59 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.674 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.3 mm? -113.03 36.0 3.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 110.761 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.808 ' O ' HG22 ' A' ' 519' ' ' THR . 0.8 OUTLIER 179.99 -35.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.551 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -40.15 -42.6 1.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -54.24 -17.63 3.08 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.5 t -48.26 -56.45 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -128.81 -10.24 4.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.78 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.914 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -81.62 -22.72 37.47 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.282 0.563 . . . . 0.0 111.129 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 518' ' ' TRP . 3.9 t70 -112.26 4.48 17.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.633 ' HA ' HD11 ' A' ' 527' ' ' ILE . 0.8 OUTLIER -130.49 -28.39 2.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.142 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.79 -26.11 3.15 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.581 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.914 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -108.97 22.77 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.166 0.508 . . . . 0.0 110.978 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.454 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.89 -3.19 1.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.263 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -138.88 -41.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.91 0.385 . . . . 0.0 110.7 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -74.91 -104.92 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.748 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.823 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -136.65 84.33 2.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.833 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -121.65 2.74 10.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.291 0.567 . . . . 0.0 110.607 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.47 21.75 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.0 OUTLIER -143.79 106.16 4.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.082 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.15 100.16 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 113.104 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 535' ' ' PHE . 22.4 p90 -164.29 -51.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.657 ' HZ ' HD13 ' A' ' 544' ' ' ILE . 20.9 p90 -93.87 20.13 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.496 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -48.21 -59.88 6.06 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.991 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.06 -2.82 12.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.617 2.211 . . . . 0.0 113.069 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -26.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.325 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -87.39 -16.45 34.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.9 pt-20 -36.66 107.06 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.93 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.95 57.21 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.766 -0.652 . . . . 0.0 114.391 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.52 -33.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 117.393 0.597 . . . . 0.0 111.517 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 175.33 -101.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.823 HG21 ' O ' ' A' ' 529' ' ' LEU . 2.2 mt -49.29 -70.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 111.599 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.1 mt-10 64.84 174.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.366 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -79.72 68.59 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.928 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -128.94 43.43 3.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.746 0.308 . . . . 0.0 111.035 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.84 35.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.901 0.382 . . . . 0.0 111.335 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.7 m80 -108.1 -17.8 13.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 64.92 -58.32 0.26 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.23 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.503 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 60.9 mt-30 93.46 127.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.114 0.566 . . . . 0.0 110.101 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 5.2 t0 -153.59 54.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.494 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 77.12 39.32 27.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 20.1 mt -97.52 -21.98 16.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.11 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 1.057 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.6 mt -109.84 -23.7 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.131 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 17.5 t -67.17 -13.4 61.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.661 0.267 . . . . 0.0 111.645 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.981 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -162.93 -119.58 0.49 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.258 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -149.47 -34.78 0.18 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.739 0.304 . . . . 0.0 110.904 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.99 42.85 2.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.812 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.93 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.75 0.31 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -166.25 131.72 1.86 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -87.19 88.35 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.1 2.533 . . . . 0.0 112.565 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 0.5 OUTLIER -130.87 -52.43 1.05 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.146 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.608 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.5 44.76 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.02 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -131.96 32.55 0.23 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.131 177.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 90.7 Cg_endo -79.82 -100.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.092 1.861 . . . . 0.0 112.621 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.8 p30 -80.3 5.39 14.89 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 111.754 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.0 mm? -99.68 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.353 0.597 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.69 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 172.52 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.897 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -36.28 -41.45 0.27 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.68 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.99 74.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.6 t -157.8 -55.88 0.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.22 0.533 . . . . 0.0 110.695 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.625 HG21 ' O ' ' A' ' 543' ' ' TYR . 5.1 t -124.12 -6.47 7.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.798 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.5 pp0? -93.01 -32.94 14.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.524 0.678 . . . . 0.0 110.179 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.64 1.74 51.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.696 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.91 -22.36 2.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.23 -32.16 1.3 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.113 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -98.39 19.6 14.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.411 0.624 . . . . 0.0 110.418 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -138.48 -3.33 1.71 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.283 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.6 -46.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -73.26 -122.12 0.08 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.1 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 530' ' ' ALA . 0.9 OUTLIER -125.71 162.77 24.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.343 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 157.66 -29.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.578 0.704 . . . . 0.0 109.613 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -10.54 59.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.705 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -89.5 126.87 56.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.36 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.32 22.17 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.719 2.28 . . . . 0.0 112.304 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -69.25 -49.08 59.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.583 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.2 OUTLIER -120.19 -40.29 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 48.62 -103.53 0.07 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.863 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.68 -6.65 9.36 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.788 2.325 . . . . 0.0 113.17 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -83.24 -27.28 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.824 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -77.99 -23.08 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.544 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 4.8 mt-10 -38.74 89.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.133 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 128.89 -8.63 6.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.618 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.88 -30.32 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.67 0.735 . . . . 0.0 112.309 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.625 ' O ' HG21 ' A' ' 520' ' ' THR . 0.1 OUTLIER -175.34 -98.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.124 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.69 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.6 OUTLIER -74.35 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.634 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.9 mt-10 76.69 168.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.059 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -47.95 -85.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.274 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.69 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.5 pp 33.99 36.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.475 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -65.99 37.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 551' ' ' GLN . 6.6 m80 -119.58 -10.78 9.55 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 65.93 -32.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.549 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 24.6 mt-30 84.0 124.74 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.474 0.654 . . . . 0.0 111.543 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 9.7 m-20 -156.65 58.87 0.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 72.34 56.73 6.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 555' ' ' ILE . 27.8 mt -109.58 -31.36 7.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.4 -18.91 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.095 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.608 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.1 t -86.73 21.89 2.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 110.906 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.015 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 170.04 -125.56 1.25 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.015 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.7 OUTLIER -151.59 -40.19 0.12 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.0 110.447 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.69 42.57 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.2 mm-40 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.361 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.756 0.312 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -178.87 124.26 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -96.65 99.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.473 2.782 . . . . 0.0 113.329 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -153.49 -57.67 0.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.321 0.581 . . . . 0.0 110.614 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 76.22 42.75 0.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.498 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.609 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -146.84 36.28 0.16 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.578 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.696 ' HB3' HD12 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -68.7 -72.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.884 1.722 . . . . 0.0 112.744 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -88.46 17.37 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.727 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 515' ' ' LEU . 3.1 mm? -113.67 43.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.157 0.503 . . . . 0.0 110.314 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 171.78 -32.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.499 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.5 p90 -38.0 -48.38 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.229 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 521' ' ' GLN . 0.1 OUTLIER -50.33 -20.38 1.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 516' ' ' HIS . 15.3 t -54.33 -53.87 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.587 ' N ' HG23 ' A' ' 519' ' ' THR . 0.6 OUTLIER -123.76 -38.06 2.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 2.8 tp60 -80.37 140.91 35.84 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER 83.74 10.81 0.45 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.387 0.613 . . . . 0.0 109.791 -177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.601 ' CA ' HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -152.08 -36.55 0.12 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.042 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 520' ' ' THR . . . -125.2 -21.75 2.02 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.031 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -114.08 23.74 12.65 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.137 0.494 . . . . 0.0 110.811 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 522' ' ' ASP . . . -144.84 -0.56 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.352 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.601 HD11 ' CA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -131.14 -39.19 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.879 0.371 . . . . 0.0 110.74 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -79.4 -100.59 0.25 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 0.7 OUTLIER -138.14 84.4 2.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.391 . . . . 0.0 111.76 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 544' ' ' ILE . . . -119.31 -18.31 8.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.601 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -12.09 61.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.543 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -86.46 128.82 55.57 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.083 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.05 46.76 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.62 2.213 . . . . 0.0 112.988 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.481 ' CE1' HG13 ' A' ' 532' ' ' ILE . 3.1 p90 -147.99 4.78 0.74 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -86.22 20.04 2.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -54.41 -83.88 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.224 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.74 -2.27 12.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.009 2.473 . . . . 0.0 112.398 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -64.42 -52.81 56.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.128 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.005 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -91.81 -40.57 11.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.5 0.667 . . . . 0.0 109.889 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.35 26.2 0.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.841 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 130.22 16.55 1.72 Allowed Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.464 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.0 mt -101.62 -41.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 117.339 0.569 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -157.42 -89.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.765 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 530' ' ' ALA . 3.6 mp -66.61 -51.13 60.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.621 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.6 OUTLIER 53.49 27.23 6.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.483 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . 92.03 -15.1 62.71 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.941 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 547' ' ' LEU . 0.5 OUTLIER -59.89 126.28 26.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.277 0.561 . . . . 0.0 110.624 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.483 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -135.81 -6.47 2.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -77.7 -27.63 50.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.186 0.517 . . . . 0.0 109.953 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 521' ' ' GLN . 6.3 m120 75.05 -28.81 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.23 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 33.0 mt-30 74.06 123.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.348 0.594 . . . . 0.0 110.646 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.746 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.1 t0 -158.26 57.52 0.46 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.535 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 69.18 23.96 76.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.889 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 558' ' ' LEU . 9.0 mt -83.94 -26.2 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.845 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.716 HG21 ' HB2' ' A' ' 510' ' ' LYS . 2.9 mt -92.61 -42.03 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.993 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.7 t -73.0 -58.85 3.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.801 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -106.6 -23.93 6.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.127 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 557' ' ' GLY . 2.1 mp 66.47 15.76 10.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.707 0.253 . . . . 0.0 111.332 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.98 18.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.61 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -170.95 123.12 0.56 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.022 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -94.81 103.37 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.518 2.812 . . . . 0.0 112.876 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 11.4 mtpp -149.31 -47.59 0.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.655 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.4 OUTLIER 73.39 44.96 0.28 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.536 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.0 t-20 -133.03 37.28 0.37 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.493 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' A' ' 556' ' ' CYS . 51.7 Cg_endo -83.19 -103.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.5 p30 -80.36 5.56 14.57 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.3 mm? -99.32 40.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.404 0.621 . . . . 0.0 109.855 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 519' ' ' THR . 0.6 OUTLIER 175.77 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.231 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.5 p90 -39.1 -41.48 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.746 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.4 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.04 79.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.6 t -170.73 -53.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 0.0 110.923 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.554 ' H ' HG23 ' A' ' 519' ' ' THR . 14.3 t -122.4 -4.47 8.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.59 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.65 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -96.85 -37.54 10.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.597 0.713 . . . . 0.0 109.964 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.38 3.62 51.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.608 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.46 -24.53 1.37 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.0 -28.07 2.54 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.343 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.773 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -103.49 21.88 15.25 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.251 0.548 . . . . 0.0 110.645 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.52 -4.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.136 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -143.71 -35.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.674 0.273 . . . . 0.0 111.086 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -68.41 -134.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.77 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 532' ' ' ILE . 8.3 mp -122.72 75.17 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.904 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -103.62 -32.28 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.744 0.783 . . . . 0.0 109.604 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.99 -15.62 62.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.612 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.682 HG21 ' HG ' ' A' ' 529' ' ' LEU . 5.0 tt -110.11 95.37 21.08 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.313 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 22.2 Cg_exo -64.86 92.82 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.27 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -122.92 -44.55 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.12 -40.24 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.048 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 57.06 -109.36 1.63 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.677 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.14 -13.62 36.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.674 2.25 . . . . 0.0 112.583 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.902 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -68.54 -25.93 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 110.674 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -93.75 -10.66 33.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.774 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 14.6 pt-20 -40.89 106.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.255 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.86 -8.25 54.01 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.141 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -33.68 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.11 0.455 . . . . 0.0 111.678 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -176.7 -96.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.904 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.3 mp -71.99 -40.09 67.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.7 mt-10 57.91 -165.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.901 0.381 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.67 49.38 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.001 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.773 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.59 -72.5 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.472 0.177 . . . . 0.0 111.342 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.472 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.86 -20.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -88.93 -22.05 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.278 . . . . 0.0 110.708 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 25.2 m-80 70.51 -5.89 1.31 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.713 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.2 mt-30 68.46 121.26 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 111.431 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.5 OUTLIER -152.66 59.29 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.24 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 74.58 51.26 8.38 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.591 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 555' ' ' ILE . 9.8 mt -103.22 -31.09 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.773 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.84 -22.39 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.881 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.605 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.6 t -100.92 34.21 2.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 152.05 139.58 2.97 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 507' ' ' ALA . 0.2 OUTLIER -90.34 -19.53 23.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.64 0.257 . . . . 0.0 111.525 -179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 31.56 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.553 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.504 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.767 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.868 0.366 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 555' ' ' ILE . 3.5 pt20 -178.97 125.78 0.25 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.761 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.564 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 10.1 Cg_endo -94.09 125.25 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.218 2.612 . . . . 0.0 112.622 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 509' ' ' PRO . 1.9 mtmt -175.07 -41.22 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.184 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 72.31 43.49 0.49 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.205 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.61 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.49 39.27 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.534 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.833 ' HB3' HD12 ' A' ' 555' ' ' ILE . 62.0 Cg_endo -80.44 -100.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.386 2.057 . . . . 0.0 112.65 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 7.8 p30 -81.87 7.61 12.41 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.5 mm? -99.83 45.4 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.26 -33.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.939 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -38.18 -39.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.524 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.48 79.65 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.616 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.9 t -166.04 -55.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 0.0 110.819 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.582 ' H ' HG23 ' A' ' 519' ' ' THR . 13.5 t -121.75 -7.73 9.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.651 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.666 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -95.65 -38.51 10.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.564 0.697 . . . . 0.0 110.14 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.6 4.32 47.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.687 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.29 -25.49 1.18 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.622 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -115.61 -27.78 2.95 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.285 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -105.44 25.95 10.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.077 0.465 . . . . 0.0 110.681 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.45 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -144.46 -4.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.778 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -133.87 -56.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 0.0 111.069 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.767 ' C ' HD12 ' A' ' 529' ' ' LEU . . . -73.72 -80.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 528' ' ' GLY . 10.0 mp -136.33 173.99 11.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.663 0.268 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 529' ' ' LEU . . . 144.29 -20.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.774 0.83 . . . . 0.0 109.615 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.449 ' HD1' HG23 ' A' ' 532' ' ' ILE . 0.0 OUTLIER -89.61 10.36 23.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.675 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.725 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -138.29 111.4 8.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.33 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.26 105.14 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 535' ' ' PHE . 5.6 p90 -166.81 -52.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HE2' HD11 ' A' ' 532' ' ' ILE . 3.7 p90 -60.14 -18.49 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 0.0 110.598 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 38.8 -123.98 1.57 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.514 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 540' ' ' GLU . 74.5 Cg_endo -74.74 -2.27 12.25 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.892 2.395 . . . . 0.0 112.934 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 535' ' ' PHE . . . -66.36 -23.94 66.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.372 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -99.04 -20.53 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.855 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 1.1 mm-40 -40.69 105.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.674 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 110.25 -10.88 31.25 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.213 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 mt -101.64 -33.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 117.248 0.524 . . . . 0.0 111.467 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.619 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 173.99 -97.89 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 543' ' ' TYR . 2.0 mp -51.18 -70.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.693 0.282 . . . . 0.0 111.703 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.4 mt-10 68.4 168.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.394 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -69.85 67.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.084 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.7 pp -140.1 40.29 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 110.655 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 36.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.5 m80 -115.08 -14.53 11.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.75 -29.78 0.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.371 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.574 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 38.3 mt-30 79.31 122.74 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.404 0.621 . . . . 0.0 111.342 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.605 ' OD2' HD21 ' A' ' 554' ' ' LEU . 13.4 p-10 -149.12 59.4 1.04 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.114 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 513' ' ' PRO . . . 63.84 25.66 69.37 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.605 HD21 ' OD2' ' A' ' 552' ' ' ASP . 17.3 mt -78.5 -23.73 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 110.803 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -100.61 -43.96 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.101 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 511' ' ' CYS . 4.8 t -72.86 -59.67 2.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.533 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.749 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -92.58 -27.45 14.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.88 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 66.01 16.67 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.77 18.59 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.119 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 16.3 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.589 ' HG3' HG23 ' A' ' 555' ' ' ILE . 4.0 pt20 -160.06 123.75 2.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 6.6 Cg_endo -94.91 113.52 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.396 2.731 . . . . 0.0 112.736 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.71 ' HB2' HG22 ' A' ' 555' ' ' ILE . 16.4 mmmt -160.57 -41.57 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.3 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.659 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 1.5 m 74.68 46.86 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.47 31.88 0.22 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.135 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.834 ' HB3' HD12 ' A' ' 555' ' ' ILE . 42.3 Cg_endo -83.92 -103.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.438 2.092 . . . . 0.0 113.042 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 4.4 p30 -74.21 -2.21 23.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.4 mm? -97.64 43.53 1.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.31 0.576 . . . . 0.0 110.336 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 519' ' ' THR . 0.1 OUTLIER 174.02 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.631 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.587 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.7 p90 -41.71 -40.63 2.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.85 79.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -165.29 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 110.506 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.58 ' H ' HG23 ' A' ' 519' ' ' THR . 7.6 t -121.15 -2.13 9.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.526 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -100.76 -36.05 9.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.599 0.714 . . . . 0.0 110.087 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.79 1.86 53.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.474 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.64 ' HA ' HD11 ' A' ' 527' ' ' ILE . 2.4 mt-10 -135.66 -24.45 1.34 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.593 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 544' ' ' ILE . . . -114.61 -27.75 3.2 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.135 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.76 25.18 11.15 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.156 0.503 . . . . 0.0 110.652 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.463 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -141.9 -5.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.321 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.99 -37.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.88 0.372 . . . . 0.0 110.675 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.87 -120.27 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.624 ' HB3' HG23 ' A' ' 532' ' ' ILE . 64.4 mt -129.19 61.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -90.01 -30.47 17.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.556 0.693 . . . . 0.0 110.246 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CD1' HG22 ' A' ' 532' ' ' ILE . 0.1 OUTLIER -71.53 -21.61 61.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.852 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 529' ' ' LEU . 4.2 tt -120.12 81.01 27.92 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.486 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.34 142.95 30.79 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.022 2.481 . . . . 0.0 112.998 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 53.5 p90 174.97 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.64 ' CZ ' HD13 ' A' ' 544' ' ' ILE . 40.9 p90 -91.96 20.29 5.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.524 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 537' ' ' PRO . . . -42.3 -52.7 5.09 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.239 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 536' ' ' GLY . 66.8 Cg_endo -74.23 -2.18 11.98 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.641 2.228 . . . . 0.0 112.72 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -87.49 -54.52 4.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.719 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.004 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -62.97 -51.87 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 109.807 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 38.25 28.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.947 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.28 17.53 2.42 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.252 -0.975 . . . . 0.0 114.438 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 539' ' ' ALA . 6.3 mt -101.57 -41.56 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.47 0.635 . . . . 0.0 110.856 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 520' ' ' THR . 0.0 OUTLIER -157.96 -95.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.64 HD13 ' CZ ' ' A' ' 535' ' ' PHE . 2.7 mp -66.04 -60.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.1 OUTLIER 51.12 -176.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 111.1 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.457 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -84.58 79.3 1.92 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.522 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.6 pp -144.46 35.12 1.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.631 0.253 . . . . 0.0 111.438 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.457 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.78 37.09 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.816 0.341 . . . . 0.0 111.711 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.6 m80 -108.4 -18.23 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 11.3 m120 66.9 -37.63 0.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.371 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.454 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 17.6 mt-30 80.65 123.89 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.389 0.614 . . . . 0.0 111.464 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -150.6 56.76 0.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.38 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.45 45.81 22.29 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.873 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.66 -19.73 13.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.0 111.104 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.3 mt -109.84 -23.74 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.261 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.659 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 11.3 t -82.46 25.79 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.662 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.01 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 164.04 -123.89 1.22 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.01 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -153.46 -38.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -138.05 45.66 2.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.115 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.678 ' HG3' HG23 ' A' ' 555' ' ' ILE . 1.5 pt20 -178.69 120.83 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 4.2 Cg_endo -97.34 112.12 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.565 2.843 . . . . 0.0 112.784 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.756 ' HB2' HG22 ' A' ' 555' ' ' ILE . 2.2 mtmt -156.2 -46.54 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.262 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.4 m 75.65 46.84 0.1 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.885 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.726 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.8 t-20 -127.84 30.23 0.19 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.08 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.888 ' HB3' HD12 ' A' ' 555' ' ' ILE . 17.3 Cg_endo -90.88 -105.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.486 2.124 . . . . 0.0 112.835 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.617 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 1.0 OUTLIER -73.54 27.01 0.07 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.7 mm? -114.22 -22.79 9.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.834 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 519' ' ' THR . 3.1 t-160 -127.09 -20.74 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.617 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 3.5 p90 -37.22 -48.97 0.9 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -62.88 83.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.348 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -168.0 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.585 ' H ' HG23 ' A' ' 519' ' ' THR . 13.1 t -127.85 -3.37 5.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.013 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -97.47 -33.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.557 0.694 . . . . 0.0 110.234 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.68 2.46 52.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.288 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.655 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.2 mt-10 -134.23 -25.48 1.55 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.464 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -115.54 -28.11 2.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -105.85 23.11 14.47 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.181 0.515 . . . . 0.0 110.794 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -140.62 -4.69 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.238 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -140.65 -38.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 110.48 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.723 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -71.96 -123.28 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 528' ' ' GLY . 8.8 mp -127.81 72.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -100.21 -31.8 11.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.716 0.769 . . . . 0.0 109.64 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.405 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.1 OUTLIER -71.91 -16.11 62.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.473 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.634 HG21 ' HG ' ' A' ' 529' ' ' LEU . 7.1 tt -115.21 83.04 9.67 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 23.5 Cg_exo -63.96 92.39 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.192 . . . . 0.0 111.85 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.74 -37.09 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.253 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.921 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.19 -40.22 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.325 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 53.12 -107.41 0.56 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -19.04 14.91 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.546 2.164 . . . . 0.0 112.621 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -71.37 -27.25 63.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 110.792 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -87.08 -12.52 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.487 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 17.0 pt-20 -39.21 106.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.839 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 102.4 -9.08 55.74 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.645 -0.707 . . . . 0.0 114.274 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -33.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.371 0.585 . . . . 0.0 111.493 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.39 -100.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.626 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.5 mp -51.49 -70.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-O 120.723 0.296 . . . . 0.0 111.521 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 3.1 mt-10 70.04 168.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -71.2 70.12 0.82 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.04 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.6 pp -138.53 41.32 2.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.685 0.278 . . . . 0.0 110.836 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.39 35.89 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' A' ' 547' ' ' LEU . 4.7 m80 -112.42 -15.57 13.08 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 15.5 m120 66.63 -48.57 0.45 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.509 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 550' ' ' ASN . 39.8 mt-30 90.5 130.26 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 110.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.425 ' HA ' ' ND2' ' A' ' 514' ' ' ASN . 5.6 t0 -159.05 54.91 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 68.22 47.99 55.34 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.85 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 24.3 mt -110.06 -26.65 9.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.654 0.264 . . . . 0.0 111.481 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.888 HD12 ' HB3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -102.83 -20.72 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.497 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 11.0 t -76.03 1.62 14.97 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.942 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -179.38 -126.75 1.04 Allowed Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.505 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.942 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -150.89 -35.56 0.14 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 43.2 3.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.796 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.966 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.774 ' HG3' HG23 ' A' ' 555' ' ' ILE . 26.2 pt20 -177.12 122.4 0.27 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 34.7 Cg_endo -94.82 144.74 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.029 2.486 . . . . 0.0 112.655 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.763 ' HB2' HG22 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 179.28 -51.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.054 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 556' ' ' CYS . 75.2 m 82.34 42.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.716 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.729 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 2.6 t-20 -107.02 -2.33 0.11 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.581 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 56.0 Cg_endo -75.52 -82.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.242 1.295 . . . . 0.0 113.155 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.719 ' O ' HD13 ' A' ' 515' ' ' LEU . 1.6 p30 -79.36 17.69 0.8 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.742 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 514' ' ' ASN . 1.1 mm? -125.83 30.81 5.62 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.616 ' O ' HG22 ' A' ' 519' ' ' THR . 4.0 t-160 -178.04 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.597 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.9 p90 -35.95 -44.82 0.38 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.138 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.33 80.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.451 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.2 t -169.95 -54.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.128 0.489 . . . . 0.0 111.041 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.547 ' H ' HG23 ' A' ' 519' ' ' THR . 14.9 t -122.74 -5.85 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.749 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.7 pp0? -94.14 -40.03 10.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.503 0.668 . . . . 0.0 109.99 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.99 3.73 40.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -134.74 -24.67 1.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.519 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.651 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -117.76 -28.18 2.35 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.448 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 547' ' ' LEU . . . -102.53 21.34 15.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.318 0.58 . . . . 0.0 110.523 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.432 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.58 -3.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.962 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.76 -38.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.821 ' C ' HD23 ' A' ' 529' ' ' LEU . . . -68.56 -134.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.696 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 528' ' ' GLY . 0.1 OUTLIER -122.41 77.78 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 112.172 -179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.893 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -105.8 -32.98 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.712 0.768 . . . . 0.0 109.771 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.414 ' CZ2' ' O ' ' A' ' 528' ' ' GLY . 0.0 OUTLIER -71.65 -19.74 62.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.463 179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 529' ' ' LEU . 2.3 tt -93.58 118.07 67.43 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.92 69.8 4.82 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.81 2.34 . . . . 0.0 112.188 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.408 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 6.4 t80 -101.86 -54.45 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.92 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.3 OUTLIER -117.34 -40.26 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.119 -179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.422 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . 57.75 -107.86 1.18 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.889 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 36.1 Cg_exo -60.29 -10.12 12.35 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.802 2.335 . . . . 0.0 113.117 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.92 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -79.01 -17.81 54.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.754 0.312 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -98.85 -16.15 18.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 110.704 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 2.2 mt-10 -41.02 103.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.19 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.51 24.03 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.049 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -102.08 -31.32 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 117.163 0.481 . . . . 0.0 111.922 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -178.28 -97.78 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.893 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.5 mp -71.22 -38.85 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 8.6 mt-10 59.01 -166.78 0.16 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.953 0.406 . . . . 0.0 111.285 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 548' ' ' MET . . . -110.68 49.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.01 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -80.33 -70.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.546 0.212 . . . . 0.0 111.239 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.449 ' H ' HD12 ' A' ' 547' ' ' LEU . 5.4 mtm 69.79 -23.72 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -82.13 -28.03 32.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 551' ' ' GLN . 5.8 m120 79.53 -25.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.79 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.596 ' HB3' ' CA ' ' A' ' 513' ' ' PRO . 31.7 mt-30 73.5 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.046 0.451 . . . . 0.0 110.232 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -161.16 31.29 0.14 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.663 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 113.97 51.89 0.47 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.655 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -109.86 -49.29 3.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.774 HG23 ' HG3' ' A' ' 508' ' ' GLN . 1.5 mp -89.78 -20.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.044 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.583 ' HA ' ' N ' ' A' ' 511' ' ' CYS . 23.4 t -62.83 -14.86 50.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.674 0.273 . . . . 0.0 111.437 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.917 ' C ' HD23 ' A' ' 558' ' ' LEU . . . -171.61 -123.12 0.68 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.917 HD23 ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -145.2 -38.06 0.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.909 0.385 . . . . 0.0 110.372 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.11 20.9 15.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 556' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.824 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.63 129.69 0.28 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.01 113.71 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.073 2.515 . . . . 0.0 112.581 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 10.6 mttm -153.7 -51.37 0.1 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.113 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.8 OUTLIER 77.87 43.65 0.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.344 179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.656 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -130.86 32.34 0.22 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.952 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 80.6 Cg_endo -79.87 -101.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 0.0 112.74 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.645 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -81.05 4.88 18.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 515' ' ' LEU . 1.8 mm? -99.76 44.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.383 0.611 . . . . 0.0 110.113 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 171.38 -34.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.736 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.645 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.3 p90 -39.08 -40.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.614 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.404 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.54 80.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.512 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.3 t -167.55 -55.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.191 0.52 . . . . 0.0 110.876 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 519' ' ' THR . 12.1 t -124.68 -5.11 7.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.661 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.6 pp0? -95.83 -38.36 10.33 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.531 0.681 . . . . 0.0 110.01 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.45 3.31 50.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.57 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.664 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.35 -25.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.605 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -116.05 -25.62 3.51 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.645 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 547' ' ' LEU . . . -106.37 20.42 19.01 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.32 0.581 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.495 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.09 -3.59 1.58 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.961 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.85 -39.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -69.47 -85.53 0.13 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.544 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 544' ' ' ILE . 13.3 mt -139.65 -147.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 104.57 -43.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.404 0.681 . . . . 0.0 109.744 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -25.05 61.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.811 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 532' ' ' ILE . 6.5 tt -102.25 89.42 1.66 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.121 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.72 82.03 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.559 2.173 . . . . 0.0 112.058 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 535' ' ' PHE . 2.5 t80 -104.7 -53.07 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.347 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.897 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 0.1 OUTLIER -120.14 -40.2 2.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.079 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 62.8 -109.92 2.99 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.432 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.29 -2.48 3.18 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.26 2.64 . . . . 0.0 114.091 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.897 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -75.44 -39.44 58.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.607 ' CA ' HD12 ' A' ' 542' ' ' ILE . . . -67.77 -35.08 78.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.946 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -1.37 74.06 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.766 -1.107 . . . . 0.0 113.69 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 143.38 -10.86 2.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.578 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.607 HD12 ' CA ' ' A' ' 539' ' ' ALA . 3.0 mt -98.7 -34.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.028 0.414 . . . . 0.0 111.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.52 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 174.07 -98.11 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 529' ' ' LEU . 1.8 mp -52.37 -67.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.995 0.426 . . . . 0.0 111.996 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 18.8 mt-10 69.17 -132.12 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.591 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -101.84 27.23 21.35 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.588 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 525' ' ' ALA . 1.3 pp -101.77 121.47 42.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.442 0.639 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -140.44 5.52 2.05 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.354 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 8.6 m-70 -95.69 -13.46 24.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.702 0.287 . . . . 0.0 110.573 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.5 m-80 70.95 -34.81 0.31 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.726 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 7.4 mt-30 86.79 125.04 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.553 0.692 . . . . 0.0 111.688 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 0.2 OUTLIER -156.88 59.41 0.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.454 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.5 56.36 6.16 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.338 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.558 ' HB2' HD13 ' A' ' 555' ' ' ILE . 24.1 mt -109.53 -30.8 7.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.0 111.194 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -106.05 -27.68 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.4 t -75.73 -6.19 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.968 0.413 . . . . 0.0 110.82 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.969 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -163.8 -129.95 1.08 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -151.28 -36.4 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 39.74 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.433 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 3.8 mm-40 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.262 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.762 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 555' ' ' ILE . 3.0 pt20 -178.01 128.66 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.34 90.03 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.276 2.651 . . . . 0.0 112.868 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.603 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.5 mtmm -143.49 -39.18 0.31 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.986 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.0 OUTLIER 74.12 46.34 0.18 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.33 0.585 . . . . 0.0 111.726 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.646 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -129.98 37.19 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.406 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.812 ' HB3' HD12 ' A' ' 555' ' ' ILE . 31.5 Cg_endo -88.05 -104.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.523 2.149 . . . . 0.0 112.574 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 16.5 p30 -75.35 5.99 5.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.1 mm? -100.82 39.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 109.76 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.622 ' O ' HG22 ' A' ' 519' ' ' THR . 0.9 OUTLIER 175.99 -31.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.161 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.612 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.6 p90 -36.57 -45.92 0.54 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.941 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.0 80.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.8 t -164.1 -56.23 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.128 0.49 . . . . 0.0 110.799 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 543' ' ' TYR . 4.8 t -127.38 -3.8 6.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.007 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 0.8 OUTLIER -97.58 -19.71 18.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.222 0.534 . . . . 0.0 110.58 179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.32 0.68 15.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.459 0.647 . . . . 0.0 110.217 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -132.98 -20.55 2.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -119.82 -33.75 1.05 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.954 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -96.04 16.89 16.69 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.461 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -134.86 -3.44 2.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.905 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -152.62 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 -179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -72.48 -110.56 0.06 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.751 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 530' ' ' ALA . 16.5 mt -114.07 -151.45 0.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.734 -0.274 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 529' ' ' LEU . . . 103.89 -21.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.396 0.678 . . . . 0.0 110.913 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.05 18.75 11.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.509 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -123.96 136.5 27.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.33 52.97 4.31 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.234 . . . . 0.0 112.581 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -143.65 -34.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.297 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.739 ' HB2' HD11 ' A' ' 532' ' ' ILE . 29.0 m-85 -85.09 20.22 1.96 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.515 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -57.02 -108.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.637 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.94 -2.86 9.69 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.664 2.243 . . . . 0.0 112.996 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.75 -25.74 19.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.299 . . . . 0.0 111.596 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -98.88 -22.1 15.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.381 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 3.2 mt-10 -37.96 92.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.71 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 135.54 -2.2 3.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.598 -0.811 . . . . 0.0 114.264 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.9 mt -101.81 -32.21 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.542 0.671 . . . . 0.0 111.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 520' ' ' THR . 0.0 OUTLIER -178.84 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.469 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.592 ' O ' HD21 ' A' ' 547' ' ' LEU . 0.9 OUTLIER -79.24 -70.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.698 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 540' ' ' GLU . 0.0 OUTLIER 73.65 175.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -50.07 -85.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.306 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.1 pp 35.89 33.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.434 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -67.18 37.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.5 m80 -112.06 -15.56 13.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.48 -46.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.205 179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.485 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 34.1 mt-30 90.43 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.285 0.564 . . . . 0.0 111.296 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 3.9 t0 -159.51 57.01 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.04 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 76.39 46.02 13.19 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.832 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 11.7 mt -109.8 -20.56 12.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 111.138 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.7 mt -109.92 -23.47 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.291 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.1 t -86.43 31.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.285 0.564 . . . . 0.0 110.653 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.025 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 160.53 -121.26 1.01 Allowed Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.025 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.1 OUTLIER -154.82 -39.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.959 0.409 . . . . 0.0 110.362 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -141.2 46.26 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 6.0 mm-40 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.52 ' CB ' HD23 ' A' ' 558' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.856 0.36 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.439 ' HG3' HG23 ' A' ' 555' ' ' ILE . 7.9 pt20 -177.04 121.38 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.86 114.06 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.371 2.714 . . . . 0.0 112.609 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 3.0 mmtp -158.37 -48.19 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.42 0.629 . . . . 0.0 110.633 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.1 OUTLIER 73.97 44.6 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.708 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.612 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.7 t-20 -133.75 36.28 0.32 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.52 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 41.1 Cg_endo -85.39 -103.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.539 2.16 . . . . 0.0 112.735 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p30 -73.09 -0.87 15.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.5 mm? -97.61 45.13 1.03 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.253 0.549 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.47 -32.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.421 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 2.0 p90 -39.15 -42.84 1.0 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.831 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -64.68 81.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -170.64 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.136 0.493 . . . . 0.0 110.838 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.583 ' H ' HG23 ' A' ' 519' ' ' THR . 15.1 t -122.74 -3.6 8.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.829 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.694 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.4 pp0? -98.82 -40.33 8.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.504 0.669 . . . . 0.0 110.116 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 2.87 51.05 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.609 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.0 OUTLIER -135.91 -25.27 1.25 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.602 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -115.46 -27.73 3.0 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.439 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.694 ' CB ' ' HA ' ' A' ' 521' ' ' GLN . . . -103.93 21.59 16.08 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-O 121.301 0.572 . . . . 0.0 110.817 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.444 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.2 -3.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.932 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -147.1 -38.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -71.08 -120.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.913 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 532' ' ' ILE . 92.2 mt -131.95 87.13 2.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -117.77 -32.09 4.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.711 0.767 . . . . 0.0 110.014 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -17.72 62.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.552 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 532' ' ' ILE . 14.2 tt -100.47 93.89 3.07 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.681 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.48 70.64 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.527 2.151 . . . . 0.0 112.152 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -103.2 -33.16 9.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.21 -38.93 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 56.09 -109.26 1.41 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.355 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -2.81 13.05 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.15 . . . . 0.0 112.569 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -84.3 -18.99 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.805 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -92.8 -17.53 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 110.309 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.555 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 1.8 mt-10 -39.39 94.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.824 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 126.01 -9.74 7.49 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.676 -0.773 . . . . 0.0 114.215 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.9 mt -101.55 -33.9 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.267 0.533 . . . . 0.0 111.208 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.555 ' CD1' HD12 ' A' ' 544' ' ' ILE . 0.0 OUTLIER 178.75 -97.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.711 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.759 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 1.8 mp -58.86 -66.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.753 0.311 . . . . 0.0 111.674 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 21.6 mt-10 81.63 18.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 548' ' ' MET . . . 71.73 -62.01 1.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.908 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 41.28 -76.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.192 0.597 . . . . 0.0 112.425 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.66 ' H ' HD12 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 80.5 -25.97 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -87.58 -27.53 22.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.017 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 70.6 -13.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.528 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.514 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 49.6 mt-30 69.87 120.92 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.471 0.653 . . . . 0.0 111.283 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.8 t0 -155.22 59.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.775 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 74.01 54.31 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.307 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.611 ' HB2' HD13 ' A' ' 555' ' ' ILE . 13.8 mt -108.09 -36.76 6.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -102.67 -22.12 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.784 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -98.26 19.84 13.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.027 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.491 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 165.48 133.3 1.48 Allowed Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.605 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.0 mp -95.6 20.06 10.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.76 24.1 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.366 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.491 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 7.3 mm-40 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.432 ' HG3' ' HA ' ' A' ' 555' ' ' ILE . 3.2 pt20 -174.75 123.35 0.37 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -94.74 105.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.443 2.762 . . . . 0.0 112.765 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 7.3 mttt -152.87 -47.08 0.1 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.756 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.549 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.5 OUTLIER 73.67 45.17 0.25 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.63 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.617 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -132.55 37.11 0.37 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.459 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 44.6 Cg_endo -84.81 -103.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.428 2.086 . . . . 0.0 112.691 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.5 OUTLIER -78.75 4.21 14.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 516' ' ' HIS . 1.5 mm? -98.09 39.44 1.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.242 0.544 . . . . 0.0 110.212 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.617 ' O ' HG22 ' A' ' 519' ' ' THR . 8.4 t-160 177.66 -34.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.115 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.6 p90 -39.1 -39.64 0.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -67.09 81.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.2 t -167.85 -56.28 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.155 0.503 . . . . 0.0 110.84 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 519' ' ' THR . 14.8 t -122.72 -6.69 8.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.877 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.67 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.2 pp0? -96.66 -40.31 9.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.585 0.707 . . . . 0.0 110.309 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.87 2.98 47.31 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.849 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -135.74 -26.09 1.23 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.663 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 544' ' ' ILE . . . -114.72 -26.57 3.57 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.611 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -106.05 21.75 16.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.268 0.556 . . . . 0.0 110.788 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.484 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -139.87 -3.0 1.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.015 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -148.5 -39.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 0.0 110.991 -179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.27 -104.27 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.73 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 528' ' ' GLY . 1.0 OUTLIER -143.73 87.41 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 112.078 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -118.68 -21.03 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.097 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -9.53 58.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.967 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 535' ' ' PHE . 0.2 OUTLIER -94.58 133.01 27.53 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.148 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.37 25.52 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.943 2.429 . . . . 0.0 114.0 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 9.2 p90 -127.27 4.45 6.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.892 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -94.95 20.47 8.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.115 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.435 ' HA2' ' CA ' ' A' ' 546' ' ' GLY . . . -50.08 -108.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.513 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.97 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.577 2.185 . . . . 0.0 112.916 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -77.14 -27.59 53.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 0.0 111.35 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.799 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -98.91 -16.15 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 14.0 pt-20 -38.99 106.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 99.74 -8.08 59.63 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.366 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.795 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.5 mt -101.57 -34.45 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 117.368 0.584 . . . . 0.0 111.269 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.41 -100.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 530' ' ' ALA . 1.6 mp -50.82 -70.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 120.71 0.29 . . . . 0.0 111.456 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 2.6 mt-10 69.95 170.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.397 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 548' ' ' MET . . . -68.85 71.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.039 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 547' ' ' LEU . 4.0 pp -144.25 38.65 1.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 0.0 110.987 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.451 ' HE2' ' HA2' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -66.77 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 547' ' ' LEU . 3.2 m80 -111.53 -15.21 13.56 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.403 ' O ' ' CD2' ' A' ' 517' ' ' TYR . 10.0 m120 66.57 -31.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.255 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 37.4 mt-30 78.71 124.15 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.498 0.666 . . . . 0.0 111.412 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 7.7 p-10 -152.37 58.86 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.954 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 73.36 51.08 10.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 555' ' ' ILE . 8.3 mt -101.52 -31.06 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.685 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.89 -21.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.965 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.592 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 1.7 t -99.47 29.09 4.18 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.01 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.508 ' HA3' ' NE2' ' A' ' 560' ' ' GLN . . . 158.5 136.05 1.99 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.552 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.9 mp -95.28 17.49 14.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.814 0.34 . . . . 0.0 111.244 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.407 ' H ' HE21 ' A' ' 560' ' ' GLN . 0.0 OUTLIER -161.09 19.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.508 ' NE2' ' HA3' ' A' ' 557' ' ' GLY . 4.4 mm-40 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.804 0.335 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -177.76 130.48 0.32 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -89.41 112.99 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.103 2.535 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.513 ' HD2' HG21 ' A' ' 555' ' ' ILE . 4.4 mttm -153.56 -52.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.622 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.84 44.68 0.08 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.159 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.639 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -132.3 33.8 0.25 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.094 177.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 512' ' ' ASN . 84.9 Cg_endo -80.49 -100.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.136 1.891 . . . . 0.0 112.666 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.2 p30 -82.08 7.48 13.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.85 41.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.385 0.612 . . . . 0.0 110.211 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.638 ' O ' HG22 ' A' ' 519' ' ' THR . 0.3 OUTLIER 174.6 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.834 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.629 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.9 p90 -37.89 -40.97 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.709 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.414 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -66.57 80.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.0 t -167.32 -56.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 0.0 110.819 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.607 ' H ' HG23 ' A' ' 519' ' ' THR . 12.9 t -122.21 -5.83 8.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.888 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.69 ' HA ' ' CB ' ' A' ' 525' ' ' ALA . 1.3 pp0? -97.29 -39.13 9.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.561 0.696 . . . . 0.0 110.051 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.36 3.32 52.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.605 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.8 mt-10 -136.37 -25.63 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 544' ' ' ILE . . . -114.86 -26.61 3.52 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.284 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 544' ' ' ILE . . . -104.14 20.43 18.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.264 0.554 . . . . 0.0 110.833 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.68 -3.25 1.88 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.461 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -150.76 -40.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -68.4 -125.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.067 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 531' ' ' TRP . 1.8 tp -129.28 84.8 2.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.897 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' A' ' 544' ' ' ILE . . . -123.0 2.65 9.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.45 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.476 ' HE1' HD12 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -101.78 22.5 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.455 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -135.29 119.03 13.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.373 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 8.5 Cg_endo -86.32 13.83 2.62 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.777 2.318 . . . . 0.0 112.087 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.68 -39.35 73.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.69 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.612 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -116.53 -40.28 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.598 0.237 . . . . 0.0 111.595 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 51.39 -107.25 0.39 Allowed Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.15 -3.0 12.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.621 2.214 . . . . 0.0 112.699 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 535' ' ' PHE . . . -81.9 -24.49 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -80.62 -12.03 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.509 0.671 . . . . 0.0 110.039 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 11.2 pt-20 -38.76 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.893 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 115.56 -8.9 19.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.025 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 539' ' ' ALA . 1.6 mt -101.86 -31.97 3.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 117.314 0.557 . . . . 0.0 111.671 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 179.02 -101.34 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 525' ' ' ALA . 1.1 mp -66.3 -48.05 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.498 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 16.8 mt-10 74.5 -133.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.506 ' O ' ' HE2' ' A' ' 548' ' ' MET . . . -98.92 23.69 35.34 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.998 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.782 ' HG ' HG22 ' A' ' 544' ' ' ILE . 1.4 pp -97.18 123.84 41.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.415 0.626 . . . . 0.0 109.814 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.506 ' HE2' ' O ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -136.98 -0.39 2.29 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.41 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 550' ' ' ASN . 1.2 p80 -87.62 -15.15 38.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.511 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.1 m-80 75.03 -27.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.582 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.8 mt-30 79.41 124.28 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.479 0.656 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.0 OUTLIER -156.32 59.3 0.57 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.709 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 72.87 55.17 6.62 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.429 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 555' ' ' ILE . 21.1 mt -109.72 -29.53 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.738 0.304 . . . . 0.0 111.347 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -109.49 -19.14 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.333 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.622 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -86.43 22.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.008 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 169.45 -126.7 1.4 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.4 OUTLIER -152.64 -39.58 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.865 0.364 . . . . 0.0 110.398 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -136.74 42.63 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.452 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 4.7 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.303 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.809 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.496 ' HB2' HG23 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -177.05 126.43 0.3 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.695 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -94.78 100.1 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.394 2.729 . . . . 0.0 113.323 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.552 ' HB2' HG21 ' A' ' 555' ' ' ILE . 39.0 mtpt -154.21 -43.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.715 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 556' ' ' CYS . 0.6 OUTLIER 72.94 44.26 0.36 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.143 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -131.55 40.41 0.6 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.784 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.876 ' HB3' HD12 ' A' ' 555' ' ' ILE . 88.1 Cg_endo -78.92 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.403 2.069 . . . . 0.0 112.401 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 0.4 OUTLIER -85.64 14.92 5.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 513' ' ' PRO . 2.4 mm? -101.92 38.67 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.267 0.556 . . . . 0.0 110.207 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 519' ' ' THR . 10.0 t-160 177.4 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.144 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.0 -42.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.006 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.405 ' O ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.54 77.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.559 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 516' ' ' HIS . 1.7 t -161.95 -55.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.584 ' H ' HG23 ' A' ' 519' ' ' THR . 2.6 t -123.73 -2.65 8.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.674 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.753 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -99.83 -25.87 14.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.412 0.625 . . . . 0.0 110.341 179.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 0.16 26.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.109 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.66 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -134.85 -21.99 1.65 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 544' ' ' ILE . . . -116.75 -31.17 1.83 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.031 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -100.47 21.05 13.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.385 0.612 . . . . 0.0 110.809 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.482 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -137.83 -2.46 1.92 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.509 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -149.48 -39.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 529' ' ' LEU . . . -70.09 -130.84 0.07 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.891 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 528' ' ' GLY . 7.0 mp -125.57 78.46 1.74 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 544' ' ' ILE . . . -107.71 -32.48 7.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.736 0.779 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.411 ' O ' ' HD3' ' A' ' 533' ' ' PRO . 0.0 OUTLIER -71.67 -14.62 62.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.962 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 532' ' ' ILE . 5.2 tt -95.61 101.63 8.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.811 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 531' ' ' TRP . 74.3 Cg_endo -74.51 64.12 5.57 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.444 2.096 . . . . 0.0 112.289 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -99.11 -43.76 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -40.28 2.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 537' ' ' PRO . . . 49.01 -104.97 0.11 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.914 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 536' ' ' GLY . 14.1 Cg_exo -69.09 -4.15 13.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.774 2.316 . . . . 0.0 113.0 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -91.7 -35.34 14.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 542' ' ' ILE . . . -77.49 -16.34 58.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 545' ' ' GLU . 19.3 pt-20 -41.27 104.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.675 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 119.29 -5.75 13.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.814 -0.707 . . . . 0.0 114.322 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.871 HD12 ' O ' ' A' ' 539' ' ' ALA . 2.8 mt -101.75 -32.85 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.449 0.625 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.521 ' CE2' HG22 ' A' ' 542' ' ' ILE . 0.0 OUTLIER 177.01 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.818 ' CG2' ' HB2' ' A' ' 530' ' ' ALA . 2.6 mp -71.52 -59.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.063 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 0.0 OUTLIER 57.54 169.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.489 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.406 ' C ' ' HG ' ' A' ' 547' ' ' LEU . . . -52.01 -85.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.297 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 544' ' ' ILE . 3.9 pp 35.92 34.67 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.527 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.2 OUTLIER -67.89 38.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 547' ' ' LEU . 9.8 m80 -113.39 -16.12 12.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 551' ' ' GLN . 1.0 OUTLIER 66.16 -38.7 0.3 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.54 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 30.2 mt-30 85.37 125.57 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.47 0.653 . . . . 0.0 111.25 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 4.7 m-20 -157.32 58.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.113 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 64.93 45.22 93.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.935 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 4.9 mt -94.84 -27.96 15.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 110.345 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.876 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.1 mp -98.99 -38.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.534 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 513' ' ' PRO . 4.1 t -77.44 -63.92 1.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.761 ' C ' HD12 ' A' ' 558' ' ' LEU . . . -93.61 -27.93 12.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.781 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 557' ' ' GLY . 1.9 mp 65.4 17.79 11.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 110.849 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -171.42 20.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.9 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.491 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 13.6 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.777 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.854 0.359 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.645 ' HG3' HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -160.47 125.55 2.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.63 86.89 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.352 2.702 . . . . 0.0 112.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB2' ' CG2' ' A' ' 555' ' ' ILE . 1.1 mtmm -139.14 -39.04 0.49 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.108 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 556' ' ' CYS . 1.1 m 74.42 46.27 0.16 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.698 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.634 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.5 t-20 -128.8 35.8 0.31 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.414 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 555' ' ' ILE . 34.3 Cg_endo -86.29 -105.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.45 2.1 . . . . 0.0 112.954 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.548 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 10.1 p30 -76.58 5.0 8.14 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.1 mm? -100.02 39.33 1.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.373 0.606 . . . . 0.0 109.969 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 519' ' ' THR . 2.2 t-160 176.89 -32.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.301 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.552 ' HB2' ' HG2' ' A' ' 521' ' ' GLN . 2.3 p90 -36.72 -42.14 0.35 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.776 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 78.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.493 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 516' ' ' HIS . 2.7 t -167.13 -55.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.239 0.542 . . . . 0.0 110.712 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.573 ' H ' HG23 ' A' ' 519' ' ' THR . 15.0 t -120.79 -5.54 9.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.575 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.2 pp0? -98.36 -38.32 9.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.637 0.732 . . . . 0.0 110.278 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.02 2.84 56.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.663 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.52 -28.08 1.02 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.51 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -111.96 -24.37 5.21 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.619 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.77 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . . . -110.2 25.57 11.63 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.156 0.503 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.01 -1.88 1.05 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.381 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -146.19 -40.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.836 0.351 . . . . 0.0 111.04 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -70.56 -108.7 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.737 ' O ' HG21 ' A' ' 544' ' ' ILE . 0.8 OUTLIER -137.72 81.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 0.0 111.973 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -115.16 0.24 13.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.114 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.79 21.27 13.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.719 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.696 ' HB ' ' CE2' ' A' ' 534' ' ' TYR . 0.1 OUTLIER -142.84 101.56 5.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.053 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.445 ' O ' ' CD1' ' A' ' 534' ' ' TYR . 74.3 Cg_endo -86.76 96.04 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.862 2.375 . . . . 0.0 115.142 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.696 ' CE2' ' HB ' ' A' ' 532' ' ' ILE . 0.1 OUTLIER -152.62 -56.26 0.13 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.474 177.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 539' ' ' ALA . 50.6 p90 -92.5 20.35 6.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.589 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -47.74 -59.49 6.04 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.886 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.0 -4.7 15.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.195 . . . . 0.0 112.748 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.64 13.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . . . -82.02 -17.8 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -38.46 106.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.973 -179.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 103.2 -8.72 53.55 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.395 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.3 mt -101.63 -32.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 117.511 0.655 . . . . 0.0 111.685 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 176.09 -101.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 529' ' ' LEU . 1.7 mp -52.97 -70.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 CA-C-O 120.798 0.332 . . . . 0.0 111.545 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.887 ' HA ' ' HB3' ' A' ' 539' ' ' ALA . 1.2 mt-10 69.29 170.59 0.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.26 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -73.91 69.72 1.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.962 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 547' ' ' LEU . 3.5 pp -137.11 41.08 2.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.797 0.332 . . . . 0.0 110.926 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.409 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.84 33.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.706 0.289 . . . . 0.0 111.732 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 547' ' ' LEU . 6.5 m-70 -114.2 -12.0 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.952 0.406 . . . . 0.0 110.045 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.66 -23.63 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.353 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 549' ' ' HIS . 36.7 mt-30 77.1 123.57 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.267 0.556 . . . . 0.0 111.236 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 1.7 t0 -154.6 57.06 0.69 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.414 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 560' ' ' GLN . . . 75.92 47.91 10.83 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.046 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.67 -21.38 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.951 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 513' ' ' PRO . 1.8 mt -109.91 -23.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.295 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 511' ' ' CYS . 2.7 t -87.02 29.76 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.019 0.438 . . . . 0.0 111.024 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 1.011 ' O ' HD23 ' A' ' 558' ' ' LEU . . . 162.09 -124.08 1.27 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -154.34 -38.94 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.909 0.385 . . . . 0.0 110.501 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -138.09 43.83 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.619 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HB2' ' HA3' ' A' ' 553' ' ' GLY . 5.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.172 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.09 124.94 0.29 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -94.22 113.47 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 112.681 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 511' ' ' CYS . 4.1 mtmt -151.89 -50.34 0.11 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.185 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 556' ' ' CYS . 0.7 OUTLIER 77.1 44.02 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.19 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.637 ' N ' ' HD3' ' A' ' 513' ' ' PRO . 1.6 t-20 -132.4 36.52 0.34 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.807 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 512' ' ' ASN . 47.6 Cg_endo -84.8 -103.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.438 2.092 . . . . 0.0 112.906 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 517' ' ' TYR . 9.3 p30 -79.12 5.32 12.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 515' ' ' LEU . 2.2 mm? -99.57 44.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.39 0.614 . . . . 0.0 109.971 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.621 ' O ' HG22 ' A' ' 519' ' ' THR . 0.0 OUTLIER 170.62 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.157 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' ' 514' ' ' ASN . 1.8 p90 -41.06 -41.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.779 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -65.57 82.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.522 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 516' ' ' HIS . 3.0 t -171.42 -55.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.53 . . . . 0.0 111.136 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.586 ' H ' HG23 ' A' ' 519' ' ' THR . 9.4 t -121.35 -11.04 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.777 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . 1.3 pp0? -93.67 -37.72 11.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.545 0.688 . . . . 0.0 110.345 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.55 4.22 47.59 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.968 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.613 ' HA ' HD11 ' A' ' 527' ' ' ILE . 1.3 mt-10 -136.02 -27.52 1.11 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.624 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -113.85 -25.42 4.23 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.618 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.683 ' HB3' ' HA ' ' A' ' 521' ' ' GLN . . . -109.05 26.39 10.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -143.48 -3.06 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.569 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -136.82 -40.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.663 0.268 . . . . 0.0 111.272 -179.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.693 ' O ' HD23 ' A' ' 529' ' ' LEU . . . -67.95 -121.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.845 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 528' ' ' GLY . 14.7 mt -129.71 52.77 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.283 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . . . -86.0 0.51 53.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.227 0.537 . . . . 0.0 110.916 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.29 19.48 15.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.8 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 532' ' ' ILE . 2.4 pt -142.86 121.47 7.4 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.669 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.85 61.36 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.659 2.239 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.522 ' CD2' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -106.77 -42.86 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.495 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 3.0 p90 -120.23 -40.26 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 33.75 -93.6 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.907 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 540' ' ' GLU . 19.0 Cg_endo -57.31 -2.02 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.549 2.833 . . . . 0.0 114.006 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 535' ' ' PHE . . . -76.0 -34.68 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.715 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -75.01 -40.58 60.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 545' ' ' GLU . 16.4 pt-20 33.07 34.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.03 -1.441 . . . . 0.0 113.953 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . 141.9 7.23 0.74 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.947 -1.12 . . . . 0.0 114.944 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 539' ' ' ALA . 3.5 mt -101.71 -37.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 117.709 0.755 . . . . 0.0 111.053 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 543' ' ' TYR . 0.0 OUTLIER -167.81 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.683 ' O ' ' HG ' ' A' ' 547' ' ' LEU . 3.9 mp -62.76 -57.3 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.988 0.423 . . . . 0.0 111.444 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.578 ' H ' ' HB3' ' A' ' 539' ' ' ALA . 1.3 mt-10 56.32 -148.82 0.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.628 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -91.87 24.5 20.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.275 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 544' ' ' ILE . 1.6 pp -108.45 120.18 41.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.258 0.551 . . . . 0.0 110.122 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 1.9 mtm -138.17 12.24 2.83 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 551' ' ' GLN . 9.4 m-70 -103.69 -11.29 17.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 549' ' ' HIS . 2.4 m-80 69.53 -23.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.586 ' HB3' ' C ' ' A' ' 513' ' ' PRO . 31.9 mt-30 78.04 123.38 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.545 0.688 . . . . 0.0 111.68 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 514' ' ' ASN . 10.1 p-10 -155.24 60.06 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.629 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 560' ' ' GLN . . . 68.47 55.2 12.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.186 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' A' ' 555' ' ' ILE . 33.1 mt -106.74 -29.25 9.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.68 -27.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.626 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . 1.2 t -76.51 -7.68 55.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 110.971 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.949 ' O ' HD23 ' A' ' 558' ' ' LEU . . . -161.43 -133.96 1.56 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER -152.37 -35.11 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.682 0.277 . . . . 0.0 110.866 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.92 34.73 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.428 ' CB ' ' HA3' ' A' ' 553' ' ' GLY . 2.9 mm-40 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 stop_ save_